<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30637</article-id><article-id pub-id-type="doi">10.7554/eLife.30637</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Severe infections emerge from commensal bacteria by adaptive evolution</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-94969"><name><surname>Young</surname><given-names>Bernadette C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6071-6770</contrib-id><email>bernadette.young@ndm.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-94970"><name><surname>Wu</surname><given-names>Chieh-Hsi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94971"><name><surname>Gordon</surname><given-names>N Claire</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94972"><name><surname>Cole</surname><given-names>Kevin</given-names></name><email>Kevin.Cole@bsuh.nhs.uk</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94973"><name><surname>Price</surname><given-names>James R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94974"><name><surname>Liu</surname><given-names>Elian</given-names></name><email>elian.liu@ouh.nhs.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94975"><name><surname>Sheppard</surname><given-names>Anna E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94976"><name><surname>Perera</surname><given-names>Sanuki</given-names></name><email>Sanuki.perera@ouh.nhs.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94977"><name><surname>Charlesworth</surname><given-names>Jane</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94978"><name><surname>Golubchik</surname><given-names>Tanya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset3"/><xref ref-type="other" rid="dataset4"/><xref ref-type="other" rid="dataset5"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><contrib contrib-type="author" id="author-94979"><name><surname>Iqbal</surname><given-names>Zamin</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset4"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-40161"><name><surname>Bowden</surname><given-names>Rory</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset3"/><xref ref-type="other" rid="dataset4"/><xref ref-type="other" rid="dataset5"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94980"><name><surname>Massey</surname><given-names>Ruth C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8154-4039</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-94981"><name><surname>Paul</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94982"><name><surname>Crook</surname><given-names>Derrick W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset4"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94983"><name><surname>Peto</surname><given-names>Timothy E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset4"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94984"><name><surname>Walker</surname><given-names>A Sarah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94985"><name><surname>Llewelyn</surname><given-names>Martin J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><contrib contrib-type="author" id="author-94986"><name><surname>Wyllie</surname><given-names>David H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-4850"><name><surname>Wilson</surname><given-names>Daniel J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0940-3311</contrib-id><email>daniel.wilson@ndm.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset4"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/><xref ref-type="other" rid="dataset3"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Nuffield Department of Medicine, Experimental Medicine Division</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Microbiology and Infectious Diseases Department</institution><institution>Oxford University Hospitals NHS Foundation Trust</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Infectious Diseases and Microbiology</institution><institution>Royal Sussex County Hospital</institution><addr-line><named-content content-type="city">Brighton</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Global Health and Infection</institution><institution>Brighton and Sussex Medical School, University of Sussex</institution><addr-line><named-content content-type="city">Brighton</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution>NIHR Health Protection Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Wellcome Trust Centre for Human Genetics</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">School of Cellular and Molecular Medicine</institution><institution>University of Bristol</institution><addr-line><named-content content-type="city">Bristol</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">National Infection Service</institution><institution>Public Health England</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff9"><label>9</label><institution>National Institute for Health Research, Oxford Biomedical Research Centre</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff10"><label>10</label><institution content-type="dept">Centre for Molecular and Cellular Physiology</institution><institution>Jenner Institute</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff11"><label>11</label><institution content-type="dept">Institute for Emerging Infections</institution><institution>Oxford Martin School, University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-23858"><name><surname>Holden</surname><given-names>Matthew TG</given-names></name><role>Reviewing Editor</role><aff><institution>University of St Andrews</institution><country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>19</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e30637</elocation-id><history><date date-type="received" iso-8601-date="2017-07-21"><day>21</day><month>07</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-12-02"><day>02</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Young et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Young et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-30637-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.30637.001</object-id><p>Bacteria responsible for the greatest global mortality colonize the human microbiota far more frequently than they cause severe infections. Whether mutation and selection among commensal bacteria are associated with infection is unknown. We investigated de novo mutation in 1163 <italic>Staphylococcus aureus</italic> genomes from 105 infected patients with nose colonization. We report that 72% of infections emerged from the nose, with infecting and nose-colonizing bacteria showing parallel adaptive differences. We found 2.8-to-3.6-fold adaptive enrichments of protein-altering variants in genes responding to <italic>rsp</italic>, which regulates surface antigens and toxin production; <italic>agr</italic>, which regulates quorum-sensing, toxin production and abscess formation; and host-derived antimicrobial peptides. Adaptive mutations in pathogenesis-associated genes were 3.1-fold enriched in infecting but not nose-colonizing bacteria. None of these signatures were observed in healthy carriers nor at the species-level, suggesting infection-associated, short-term, within-host selection pressures. Our results show that signatures of spontaneous adaptive evolution are specifically associated with infection, raising new possibilities for diagnosis and treatment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Staphylococcus aureus</italic> </kwd><kwd>within-host evolution</kwd><kwd>infection</kwd><kwd>virulence</kwd><kwd>pathogen genomics</kwd><kwd>adaptation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>Health Innovation Challenge Fund WT098615/Z/12/Z</award-id><principal-award-recipient><name><surname>Crook</surname><given-names>Derrick W</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><award-id>Oxford NIHR Biomedical Research Centre</award-id><principal-award-recipient><name><surname>Crook</surname><given-names>Derrick W</given-names></name><name><surname>Peto</surname><given-names>Timothy E</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000276</institution-id><institution>Department of Health</institution></institution-wrap></funding-source><award-id>Health Innovation Challenge Fund HICF-T5-358</award-id><principal-award-recipient><name><surname>Crook</surname><given-names>Derrick W</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>Sir Henry Dale Fellowship 101237/Z/13/Z</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Institut Mérieux</institution></institution-wrap></funding-source><award-id>Mérieux Research Grant</award-id><principal-award-recipient><name><surname>Bowden</surname><given-names>Rory</given-names></name><name><surname>Crook</surname><given-names>Derrick W</given-names></name><name><surname>Wilson</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002141</institution-id><institution>Public Health England</institution></institution-wrap></funding-source><award-id>HPRU in Healthcare Associated Infections and Antimicrobial Resistance HPRU-2012-10041</award-id><principal-award-recipient><name><surname>Crook</surname><given-names>Derrick W</given-names></name><name><surname>Peto</surname><given-names>Timothy E</given-names></name><name><surname>Walker</surname><given-names>A Sarah</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><award-id>HPRU in Healthcare Associated Infections and Antimicrobial Resistance HPRU-2012-10041</award-id><principal-award-recipient><name><surname>Crook</surname><given-names>Derrick W</given-names></name><name><surname>Peto</surname><given-names>Timothy E</given-names></name><name><surname>Walker</surname><given-names>A Sarah</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>Sir Henry Dale Fellowship 101237/Z/13/Z</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>Sir Henry Dale Fellowship 102541/Z/13/Z</award-id><principal-award-recipient><name><surname>Iqbal</surname><given-names>Zamin</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>Sir Henry Dale Fellowship 102541/Z/13/Z</award-id><principal-award-recipient><name><surname>Iqbal</surname><given-names>Zamin</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>Research Training Fellowship 101611/Z/13/Z</award-id><principal-award-recipient><name><surname>Young</surname><given-names>Bernadette C</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>Wellcome Trust Centre for Human Genetics core funding 090532/Z/09/Z</award-id><principal-award-recipient><name><surname>Bowden</surname><given-names>Rory</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Life-threatening <italic>S. aureus</italic> infections emerge from commensal nose bacteria in association with repeatable adaptive evolution.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Infections remain a leading cause of global mortality, with bacterial pathogens among the greatest concern (<xref ref-type="bibr" rid="bib24">GBD 2015 Mortality and Causes of Death Collaborators, 2016</xref>). However, many of the bacteria imposing the greatest burden of mortality, such as <italic>Staphylococcus aureus</italic>, are frequently found as commensal components of the body's microbiota (<xref ref-type="bibr" rid="bib85">Turnbaugh et al., 2007</xref>). For them, infection is a relatively uncommon event that is often unnecessary (<xref ref-type="bibr" rid="bib4">Casadevall et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Méthot and Alizon, 2014</xref>), and perhaps disadvantageous (<xref ref-type="bibr" rid="bib3">Brown et al., 2012</xref>), for onward transmission. Genomics is shedding light on important bacterial traits such as host-specificity, toxicity and antimicrobial resistance (<xref ref-type="bibr" rid="bib78">Sheppard et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Laabei et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Chewapreecha et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib18">Earle et al., 2016</xref>). These approaches offer new opportunities to understand the role of genetics and within-host evolution in the outcome of human interactions with major bacterial pathogens (<xref ref-type="bibr" rid="bib14">Didelot et al., 2016</xref>).</p><p>Several lines of evidence support a plausible role for within-host evolution influencing the virulence of bacterial pathogens. Common bacterial infections, including <italic>S. aureus</italic>, are often associated with colonization of the nose by a genetically similar strain. In these patients, the nose is considered the likely source of infection because the nose is more often the site of asymptomatic colonization than any other body site (<xref ref-type="bibr" rid="bib86">von Eiff et al., 2001</xref>; <xref ref-type="bibr" rid="bib40">Kluytmans et al., 1997</xref>; <xref ref-type="bibr" rid="bib89">Yang et al., 2010</xref>). Genome sequencing suggests that bacteria mutate much more quickly than previously accepted, and this confers a potent ability to adapt, for example evolving antimicrobial resistance de novo within individual patients (<xref ref-type="bibr" rid="bib36">Howden et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Eldholm et al., 2014</xref>). Opportunistic pathogens infecting cystic fibrosis patients have been found to rapidly adapt to the lung environment, with strong evidence of parallel evolution across patients (<xref ref-type="bibr" rid="bib48">Lieberman et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Marvig et al., 2013</xref>; <xref ref-type="bibr" rid="bib55">Markussen et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Lieberman et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Marvig et al., 2015</xref>). However, the selection pressures associated with antimicrobial resistance and opportunistic infections of cystic fibrosis patients may not typify within-host adaptation in common commensal pathogens that have co-evolved with humans for thousands or millions of years (<xref ref-type="bibr" rid="bib60">Moeller et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Lees et al., 2017</xref>).</p><p>Candidate gene studies have demonstrated that substitutions in certain regions, notably quorum-sensing systems such as the <italic>S. aureus</italic> accessory gene regulator (<italic>agr</italic>), arise particularly quickly in vivo and in culture (<xref ref-type="bibr" rid="bib84">Traber et al., 2008</xref>). The <italic>agr</italic> operon encodes a pheromone that coordinates a shift at higher cell densities from production of surface proteins promoting biofilm formation to production of secreted toxins and proteases promoting inflammation and dispersal (<xref ref-type="bibr" rid="bib63">Novick and Geisinger, 2008</xref>). Mutants typically produce the pheromone but no longer respond to it (<xref ref-type="bibr" rid="bib64">Painter et al., 2014</xref>). The evolution of <italic>agr</italic> has been variously ascribed to directional selection (<xref ref-type="bibr" rid="bib75">Sakoulas et al., 2009</xref>), balancing selection (<xref ref-type="bibr" rid="bib72">Robinson et al., 2005</xref>), social cheating (<xref ref-type="bibr" rid="bib66">Pollitt et al., 2014</xref>) and life-history trade-off (<xref ref-type="bibr" rid="bib79">Shopsin et al., 2010</xref>). However, the role of <italic>agr</italic> mutants in infection remains unclear, since they are frequently sampled from both asymptomatic carriage and severe infections (<xref ref-type="bibr" rid="bib80">Smyth et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">Painter et al., 2014</xref>).</p><p>Whole-genome sequencing case studies add weight to the idea that within-host evolution plays an important role in infection. In one persistent <italic>S. aureus</italic> infection, a single mutation was sufficient to permanently activate the stringent stress response, reducing growth, colony size and experimentally measured infection severity (<xref ref-type="bibr" rid="bib23">Gao et al., 2010</xref>). In another patient, we found that bloodstream bacteria differed from those initially colonizing the nose by several mutations including loss-of-function of the <italic>rsp</italic> regulator (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>). Functional follow-up revealed that the <italic>rsp</italic> mutant expressed reduced cytotoxicity (<xref ref-type="bibr" rid="bib43">Laabei et al., 2015</xref>), but maintained the ability to cause disseminated infection (<xref ref-type="bibr" rid="bib12">Das et al., 2016</xref>). Unexpectedly, we found that bloodstream-infecting bacteria exhibit lower cytotoxicity than nose-colonizing bacteria more generally (<xref ref-type="bibr" rid="bib43">Laabei et al., 2015</xref>). These results raise the question: are unique hallmarks of de novo mutation and selection associated with bacterial evolution in severely infected patients?</p><p>We addressed this question by investigating the genetic variants arising from within-patient evolution of <italic>S. aureus</italic> sampled from 105 patients with concurrent nose colonization and blood or deep tissue infection. We annotated variants to test for systematic differences between colonizing and infecting bacteria. We discovered several groups of genes showing significant enrichments of protein-altering variants compared to other genes, indicating adaptive evolution. For genes implicated in pathogenesis, adaptive mutants were limited to infecting bacteria, while other pathways showed adaptation in the nose and infection site. Adaptive enrichments were not observed in asymptomatic carriers, nor between unrelated bacteria, indicating evolution in response to infection-associated, within-host selection pressures. Our results reveal that adaptive evolution of genes involved in regulation, toxin production, abscess formation, cell-cell communication and bacterial-host interaction drives parallel differentiation between commensal constituents of the nose and infecting bacteria, providing new insights into the evolution of infection in a major pathogen.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Infecting bacteria are typically descended from the patient’s commensal bacteria</title><p>We identified 105 patients suffering severe <italic>S. aureus</italic> infections admitted to hospitals in Oxford and Brighton, England, for whom we could recover contemporaneous nose swabs from admission screening. Of the 105 patients, 55 had bloodstream infections, 37 had soft tissue infections and 13 had bone and joint infections (<xref ref-type="table" rid="table1">Table 1</xref>). The infection was most often sampled on the same day as the nose, with an interquartile range of 1 day earlier to 2 days later (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30637.002</object-id><label>Table 1.</label><caption><title>Distribution of infection types and relatedness of nose-colonizing and infecting <italic>S. aureus</italic> among 105 patients revealed by genomic comparison.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top">Infection sites</th><th colspan="3" valign="top">Relation of nose-colonizing to infecting bacteria</th></tr><tr><th rowspan="2" valign="top">Unrelated <break/>(≥1104 variants)</th><th colspan="2" valign="top">Closely related <break/>(≤66 variants)</th></tr><tr><th valign="top">Zero shared genotypes</th><th valign="top">One shared genotype</th></tr></thead><tbody><tr><td valign="top">Bloodstream</td><td valign="top">4</td><td valign="top">43</td><td valign="top">8</td></tr><tr><td valign="top">Soft tissue</td><td valign="top">4</td><td valign="top">23</td><td valign="top">10</td></tr><tr><td valign="top">Bone and joint</td><td valign="top">2</td><td valign="top">8</td><td valign="top">3</td></tr><tr><td valign="top">Total</td><td valign="top">10</td><td valign="top">74</td><td valign="top">21</td></tr></tbody></table></table-wrap><p>To discover de novo mutations within and between <italic>S. aureus</italic> in the nose and infection site, we whole-genome sequenced 1163 bacterial colonies, a median of 5 per site. We detected single-nucleotide polymorphisms (SNPs) and short insertions/deletions (indels) using previously developed, combined reference-based mapping and de novo assembly approaches (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Iqbal et al., 2012</xref>). We identified 35 distinct strains, defined by multilocus sequence type (ST), across patients (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). As expected (<xref ref-type="bibr" rid="bib86">von Eiff et al., 2001</xref>), most patients possessed extremely closely related nose-colonizing and infecting bacteria, sharing the same ST and differing by 0–66 variants (95 patients). The nose-colonizing and infecting bacteria of nine patients were unrelated, possessing different STs and differing by 9398–50573 variants (e.g. <xref ref-type="fig" rid="fig1">Figure 1A</xref>). In one further patient, we deemed the nose-colonizing and infecting bacteria to be unrelated despite sharing the same ST because they differed by 1104 variants, far outside the within-ST variation evident in any individual nose or infection site (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), and corresponding to around 70 years of divergence based on our previous estimates of within-host evolution (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>). In 9/95 patients with extremely closely related nose-colonizing and infecting bacteria, another, unrelated ST was also present in the nose (six patients) or the infection site (three patients); we excluded these unrelated bacteria from further analysis. After excluding variants differentiating unrelated nose-colonizing and infecting bacteria, we catalogued 1322 de novo mutations that we deemed arose within the 105 patients.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30637.003</object-id><label>Figure 1.</label><caption><title>Infection-causing <italic>S. aureus</italic> form closely related but distinct populations descended from nose-colonizing bacteria in the majority of infections.</title><p>Bacteria sampled from the nose and infection site of 105 patients formed one of three population structures, illustrated with example haplotrees: (<bold>A</bold>) Unrelated populations differentiated by many variants. (<bold>B</bold>) Highly related populations separated by few variants. (<bold>C</bold>) Highly related populations with one genotype in common. Reconstructing the ancestral genotype in each patient helped identify the ancestral population: (<bold>D</bold>) Nose-colonizing bacteria ancestral. (<bold>E</bold>) Ambiguous ancestral population. (<bold>F</bold>) Infection site bacteria ancestral. (<bold>G</bold>) Phylogeny illustrating the working hypothesis that variants differentiating highly related nose-colonizing and infection-causing bacteria would be enriched for variants that promote, or are promoted by, infection. In <bold>A–F</bold>, haplotree nodes represent observed genotypes sampled from the nose (white) or infection site (grey), with area proportional to genotype frequency, or unobserved intermediate genotypes (black). Edges represent mutations. Patient identifiers and sample sizes (<bold>n</bold>) are given. In <bold>A–G</bold>, edge color indicates that mutations occurring on those branches correspond to B-class variants between nose-colonizing and infection-causing bacteria (blue), C-class variants among nose-colonizing bacteria (gold) or D-class variants among infection-causing bacteria (red). Black dashed edges indicate ancestral lineages. A B C.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig1-v1"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30637.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Distribution of the number of variants identified within 105 severely infected patients, by class.</title><p>Three classes of variants were identified: those representing genuine differences <italic>between</italic> nose-colonizing and infection populations (<italic>B</italic>-class), variants specific to the nose-<italic>colonizing</italic> population (<italic>C</italic>-class) and variants specific to the <italic>disease</italic>-causing infection population (<italic>D</italic>-class). The number of variants is shown on a piecewise-linear axis, with horizontal positioning permuted to assist visualization. Where nose-colonizing and infecting bacteria possessed different multilocus sequence types, the number of variants between those populations is colored red. When the number of B-class variants was 66 or less, nose-colonizing and infecting bacteria were considered related, since a similar range of (C-class) diversity was observed within the nose-colonizing populations of bacteria with the same multilocus sequence type. When the number of B-class variants was 1104 or more, nose-colonizing and infecting bacteria were considered unrelated.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig1-figsupp1-v1"/></fig></fig-group><p>In patients with closely related strains, the within-patient population structure was always consistent with a unique migration event from the nose to the infection site, or occasionally, vice versa. Infecting and nose-colonizing bacteria usually formed closely related but distinct populations with no shared genotypes (74/95 patients, e.g. <xref ref-type="fig" rid="fig1">Figure 1B</xref>), separated by a mean of 5.7 variants. There was never more than one identical genotype between nose-colonizing and infecting bacteria, (21/95 patients, e.g. <xref ref-type="fig" rid="fig1">Figure 1C</xref>), indicating that the migration event from one population to the other involved a small number of founding bacteria (<xref ref-type="bibr" rid="bib61">Moxon and Murphy, 1978</xref>; <xref ref-type="bibr" rid="bib54">Margolis and Levin, 2007</xref>; <xref ref-type="bibr" rid="bib67">Prajsnar et al., 2012</xref>). In such patients, the shared genotype likely represents the migrating genotype itself. Population structure did not differ significantly between infection types (p=0.38, <xref ref-type="table" rid="table1">Table 1</xref>). Genetic diversity in the nose (mean pairwise distance, <italic>π</italic> = 2.8 variants) was similar to that previously observed in asymptomatic nasal carriers (<xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>) (Reference Panel I, <italic>π</italic> = 4.1, p=0.13), but was significantly lower in the infection site (<italic>π</italic> = 0.6, p=10<sup>–10.0</sup>), revealing limited diversification post-infection.</p><p>In most patients, the infection appeared to be descended from the nose. We used 1149 sequences from other patients and carriers (Reference Panel II) to reconstruct the most recent common ancestor (MRCA) for the 95/105 (90%) patients with related nose-colonizing and infecting bacteria. We thereby distinguished wild type from mutant alleles. In 49 such patients, we could determine the ancestral population. The nose population was likely ancestral in 39/49 (80% of patients with related strains, or 72% of all patients) because all infecting bacteria shared de novo mutations in common that distinguished them from the MRCA, whereas nose-colonizing bacteria did not. In 16 of those, confidence was high because both mutant and ancestral alleles were observed in the nose, confirming it as the origin of the de novo mutation (e.g. <xref ref-type="fig" rid="fig1">Figure 1D</xref>). Conversely, in 10/49 patients, bacteria colonizing the nose were likely descended from blood or deep tissue infections (20% of patients with related strains, or 18% of all patients) (e.g. <xref ref-type="fig" rid="fig1">Figure 1F</xref>). Confidence was high for just three of those patients, and they showed unusually high diversity (Supplementary data, P063, P072, P093), suggesting that in persistent infections, infecting bacteria can recolonize the nose.</p></sec><sec id="s2-2"><title>Protein-truncating mutants are over-represented within infected patients</title><p>To help identify variants that could promote, or be promoted by, infection of the blood and deep tissue by bacteria colonizing the nose, we reconstructed within-patient phylogenies and classified variants by their position in the phylogeny. Sequencing multiple colonies per site enabled us to classify variants into those representing genuine differences <italic>between</italic> nose-colonizing and infection populations (<italic>B</italic>-class), variants specific to the nose-<italic>colonizing</italic> population (<italic>C</italic>-class) and variants specific to the <italic>disease</italic>-causing infection population (<italic>D</italic>-class). We hypothesized that B-class variants would be most enriched for variants promoting, or promoted by, infection, if such variants occur (<xref ref-type="fig" rid="fig1">Figure 1G</xref>).</p><p>We cross-classified variants by their predicted functional effect: synonymous, non-synonymous or truncating within protein-coding sequences, or non-coding (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). As expected, the prevailing tendency of selection within patients was to conserve protein sequences, with <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> ratios indicating rates of non-synonymous change 0.55, 0.68 and 0.63 times the rate expected under strict neutral evolution for B-, C- and D-class variants, respectively.</p><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.30637.005</object-id><label>Table 2.</label><caption><title>Cross-classification of variants within patients by phylogenetic position and predicted functional effect, and comparison to asymptomatic nose carriers.</title><p>Neutrality indices (<xref ref-type="bibr" rid="bib58">McDonald and Kreitman, 1991</xref>; <xref ref-type="bibr" rid="bib70">Rand and Kann, 1996</xref>) were defined as the odds ratio of mutation counts relative to synonymous variants in patients versus asymptomatic nose carriers (Reference Panel I). Those significant at p&lt;0.05 and p&lt;0.005 are emboldened and underlined respectively.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom"/><th colspan="5" valign="bottom">Number of variants (Neutrality index)</th></tr><tr><th>Phylogenetic position</th><th>Synonymous</th><th>Non-synonymous</th><th>Protein truncating</th><th>Non-coding</th><th>Total</th></tr></thead><tbody><tr><td colspan="7" valign="bottom">Patients with severe infections (<italic>n</italic> = 105)</td></tr><tr><td>Between nose-colonization and infection site (B-class)</td><td>93</td><td>265 (1.1)</td><td><bold>39 (3.1)</bold></td><td>140 (1.2)</td><td>537</td></tr><tr><td>Within nose-colonization <break/>(C-class)</td><td>93</td><td>325 (1.3)</td><td><bold>59 (4.7)</bold></td><td>145 (1.3)</td><td>622</td></tr><tr><td>Within infection site <break/>(D-class)</td><td>26</td><td>82 (1.2)</td><td><bold>15 (4.3)</bold></td><td>40 (1.3)</td><td>163</td></tr><tr><td>Total</td><td>212</td><td>672 (1.2)</td><td><bold>113 (3.9)</bold></td><td>325 (1.3)</td><td>1322</td></tr><tr><td colspan="7" valign="bottom">Asymptomatic carriers (<xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>) (Reference panel I, for comparison, <italic>n</italic> = 13)</td></tr><tr><td>Within nose-colonization <break/>(C-class)</td><td>37</td><td>97</td><td>5</td><td>45</td><td>184</td></tr></tbody></table></table-wrap><p>In a longitudinal study of one long-term carrier, we previously reported that a burst of protein-truncating variants punctuated the transition from asymptomatic nose carriage to infection (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>). Here, we found a 3.9-fold over-abundance of protein-truncating variants of all phylogenetic classes in infected patients compared to asymptomatic carriers (Reference Panel I, p=0.002, <xref ref-type="table" rid="table2">Table 2</xref>), supporting the conclusion that loss-of-function mutations are disproportionately associated with evolution within infected patients. This may reflect a reduction in the efficiency with which selection removes deleterious protein-truncating mutations, and provides evidence of a systematic difference in selection within severely infected patients.</p></sec><sec id="s2-3"><title>Quorum sensing and cell-adhesion proteins exhibit adaptive evolution between nose-colonizing and infecting bacteria</title><p>We hypothesized that variants associated with infection would be enriched among the protein-altering B-class variants between the nose and infection site (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Therefore, we aggregated mutations by genes in a well-annotated reference genome, MRSA252, and tested each gene for an excess of non-synonymous and protein-truncating B-class variants compared to other genes, taking into account the length of the genes. Aggregating by gene was necessary because 1318/1322 variants were unique to single patients. The two exceptions involved non-coding variants arising in two patients each, one B-class variant 130 bases upstream of <italic>azlC</italic>, an azaleucine resistance protein (SAR0010), and one D-class variant 88 bases upstream of <italic>eapH</italic>1, a secreted serine protease inhibitor (SAR2295) (<xref ref-type="bibr" rid="bib83">Stapels et al., 2014</xref>).</p><p>We found a significant excess of five protein-altering B-class variants representing a 58.3-fold enrichment in <italic>agrA</italic>, which encodes the response regulator that mediates activation of the quorum-sensing system at high cell densities (p=10<sup>–7.5</sup>, <xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="table" rid="table3">Table 3</xref>). The <italic>clfB</italic> gene encoding clumping factor B, which binds human fibrinogen and loricrin (<xref ref-type="bibr" rid="bib22">Foster et al., 2013</xref>), showed an excess of five protein-altering B-class variants, representing a 15.9-fold enrichment that was near genome-wide significance after multiple testing correction (p=10<sup>–4.7</sup>). Both signals of enrichment produced neutrality indices exceeding one, consistent with adaptive evolution (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.30637.006</object-id><label>Figure 2.</label><caption><title>Genes, ontologies and pathways enriched for protein-altering substitutions between nose-colonizing and infection-causing bacteria within infected patients.</title><p>(<bold>A</bold>) Significance of enrichment of 2650 individual genes. (<bold>B</bold>) Significance of enrichment of 552 gene sets defined by BioCyc gene ontologies. (<bold>C</bold>) Significance of enrichment of 248 gene sets defined by SAMMD expression pathways. Genes, pathways and ontologies that approach or exceed a Bonferroni-corrected significance threshold of <italic>α</italic> = 0.05, weighted for the number of tests per category, (red lines) are named.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig2-v1"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30637.007</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Genes, ontologies and pathways enriched for protein-altering transient variants within nose-colonizing and infection-causing bacteria.</title><p>(<bold>A</bold>) Significance of enrichment of 2650 individual genes. SAR1461 encodes Pbp2, penicillin-binding protein 2. (<bold>B</bold>) Significance of enrichment of 552 gene sets defined by BioCyc gene ontologies. (<bold>C</bold>) Significance of enrichment of 248 gene sets defined by SAMMD expression pathways. C-class variants among nose-colonizing bacteria are colored gold, D-class variants among infection-causing bacteria are colored red. Genes, pathways and ontologies that approach or exceed a Bonferroni-corrected significance threshold of <italic>α</italic> = 0.05, weighted for the number of tests per category, (red lines) are named.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig2-figsupp1-v1"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30637.008</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Gene set enrichment analysis of B-class mutants occurring in the nose or the infection site.</title><p>Each point indicates the –log10 p-values of two tests for enrichment of protein-altering variants found among mutants in nose-colonizing bacteria vs infection-causing bacteria. The shape of each point represents the type of enrichment tested (squares: within 2650 genes in MRSA252, triangles: 552 BioCyc gene ontologies, circles: 248 SAMMD expression pathways). A line of 1:1 correspondence is plotted in red. A -log<sub>10</sub>p-value above 5.2, 4.5 or 4.2 was considered genome-wide significant for loci, gene ontologies or expression pathways, respectively.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig2-figsupp2-v1"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30637.009</object-id><label>Figure 2—figure supplement 3.</label><caption><title>Genes, ontologies and pathways enriched for protein-altering variants among longitudinally sampled asymptomatic nasal carriers.</title><p>(<bold>A</bold>) Significance of enrichment of 2650 individual genes. (<bold>B</bold>) Significance of enrichment of 552 gene sets defined by BioCyc gene ontologies. (<bold>C</bold>) Significance of enrichment of 248 gene sets defined by SAMMD expression pathways. Genes, pathways and ontologies that approach or exceed a Bonferroni-corrected significance threshold of <italic>α</italic> = 0.05, weighted for the number of tests per category, (red lines) are named.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig2-figsupp3-v1"/></fig></fig-group><table-wrap id="table3" position="float"><object-id pub-id-type="doi">10.7554/eLife.30637.010</object-id><label>Table 3.</label><caption><title>Genes, gene ontologies and expression pathways exhibiting the most significant enrichments or depletions of protein-altering B-class variants separating nose and infection site bacteria.</title><p>Enrichments below one represent depletions. The total number of variants and genes available for analysis differed by database. A -log<sub>10 </sub>p-value above 5.2, 4.5 or 4.2 was considered genome-wide significant for loci, gene ontologies or expression pathways respectively (in bold).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Gene group</th><th colspan="2" valign="top">No. protein-altering <break/>B-class variants</th><th colspan="2" valign="top">Cumulative lengthof genes (kb)</th><th colspan="2" valign="top">Enrichment</th><th valign="top">Significance (-log<sub>10</sub> p value)</th></tr><tr><th valign="top">Locus</th><th valign="bottom"/><th valign="bottom"/><th valign="bottom"/><th valign="bottom"/><th valign="bottom"/><th valign="bottom"/><th valign="bottom"/></tr></thead><tbody><tr><td valign="top"><italic>agrA</italic></td><td valign="bottom">5</td><td valign="bottom"/><td valign="bottom">0.7</td><td valign="bottom"/><td valign="bottom">58.27</td><td valign="bottom"/><td valign="bottom"><bold>7.53</bold></td></tr><tr><td valign="top"><italic>clfB</italic></td><td valign="bottom">5</td><td valign="bottom"/><td valign="bottom">2.6</td><td valign="bottom"/><td valign="bottom">15.87</td><td valign="bottom"/><td valign="bottom">4.70</td></tr><tr><td valign="top">Total</td><td valign="bottom">289</td><td valign="bottom"/><td valign="bottom">2363.8</td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="top"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="top">BioCyc Gene Ontology (<xref ref-type="bibr" rid="bib5">Caspi et al., 2016</xref>)</td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="top">Cell wall</td><td valign="bottom">18</td><td valign="bottom"/><td valign="bottom">30.9</td><td valign="bottom"/><td valign="bottom">5.02</td><td valign="bottom"/><td valign="bottom"><bold>7.03</bold></td></tr><tr><td valign="top">Cell adhesion</td><td valign="bottom">13</td><td valign="bottom"/><td valign="bottom">17.2</td><td valign="bottom"/><td valign="bottom">6.44</td><td valign="bottom"/><td valign="bottom"><bold>6.47</bold></td></tr><tr><td valign="top">Pathogenesis</td><td valign="bottom">31</td><td valign="bottom"/><td valign="bottom">112.5</td><td valign="bottom"/><td valign="bottom">2.41</td><td valign="bottom"/><td valign="bottom">4.44</td></tr><tr><td valign="top">Total</td><td valign="bottom">288</td><td valign="bottom"/><td valign="bottom">2359.3</td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="top"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="top">SAMMD Expression Pathway</td><td valign="bottom"><italic>Down-regulated</italic></td><td valign="bottom"><italic>Up-regulated</italic></td><td valign="bottom"><italic>Down-regulated</italic></td><td valign="bottom"><italic>Up-regulated</italic></td><td valign="bottom"><italic>Down-regulated</italic></td><td valign="bottom"><italic>Up-regulated</italic></td><td valign="bottom"/></tr><tr><td valign="top">Ovispirin-1 (<italic><xref ref-type="bibr" rid="bib65">Pietiäinen et al., 2009</xref></italic>)</td><td valign="bottom">40</td><td valign="bottom">7</td><td valign="bottom">121.2</td><td valign="bottom">142.9</td><td valign="bottom">2.65</td><td valign="bottom">0.39</td><td valign="bottom"><bold>7.80</bold></td></tr><tr><td valign="top">Temporin L (<xref ref-type="bibr" rid="bib65">Pietiäinen et al., 2009</xref>)</td><td valign="bottom">42</td><td valign="bottom">14</td><td valign="bottom">125.1</td><td valign="bottom">156.1</td><td valign="bottom">2.78</td><td valign="bottom">0.74</td><td valign="bottom"><bold>6.86</bold></td></tr><tr><td valign="top"><italic>rsp</italic> (<xref ref-type="bibr" rid="bib46">Lei et al., 2011</xref>)</td><td valign="bottom">27</td><td valign="bottom">1</td><td valign="bottom">61.1</td><td valign="bottom">13.7</td><td valign="bottom">3.61</td><td valign="bottom">0.60</td><td valign="bottom"><bold>6.35</bold></td></tr><tr><td valign="top"><italic>agrA</italic> (RN27) (<xref ref-type="bibr" rid="bib17">Dunman et al., 2001</xref>)</td><td valign="bottom">9</td><td valign="bottom">30</td><td valign="bottom">41.0</td><td valign="bottom">85.0</td><td valign="bottom">1.83</td><td valign="bottom">2.94</td><td valign="bottom"><bold>5.57</bold></td></tr><tr><td valign="top">VISA-vs-VSSA (Mu50 vs N315) (<xref ref-type="bibr" rid="bib10">Cui et al., 2005</xref>)</td><td valign="bottom">0</td><td valign="bottom">17</td><td valign="bottom">0</td><td valign="bottom">34.4</td><td valign="bottom">0</td><td valign="bottom">3.95</td><td valign="bottom"><bold>5.27</bold></td></tr><tr><td valign="top">VISA-vs-VSSA (Mu50 vs Mu50-P) (<xref ref-type="bibr" rid="bib10">Cui et al., 2005</xref>)</td><td valign="bottom">0</td><td valign="bottom">17</td><td valign="bottom">0</td><td valign="bottom">36.7</td><td valign="bottom">0</td><td valign="bottom">3.70</td><td valign="bottom"><bold>4.90</bold></td></tr><tr><td valign="top">VISA-vs-VSSA (isolate pair 2) (<xref ref-type="bibr" rid="bib37">Howden et al., 2008</xref>)</td><td valign="bottom">14</td><td valign="bottom">3</td><td valign="bottom">26.9</td><td valign="bottom">59.7</td><td valign="bottom">4.06</td><td valign="bottom">0.39</td><td valign="bottom"><bold>4.71</bold></td></tr><tr><td valign="top"><italic>sarA</italic> (RN27) (<xref ref-type="bibr" rid="bib17">Dunman et al., 2001</xref>)</td><td valign="bottom">6</td><td valign="bottom">23</td><td valign="bottom">49.9</td><td valign="bottom">57.7</td><td valign="bottom">0.97</td><td valign="bottom">3.22</td><td valign="bottom"><bold>4.59</bold></td></tr><tr><td valign="top"><italic>agrA</italic> (UAMS-1 OD 1.0) (<xref ref-type="bibr" rid="bib6">Cassat et al., 2006</xref>)</td><td valign="bottom">0</td><td valign="bottom">5</td><td valign="bottom">0</td><td valign="bottom">2.7</td><td valign="bottom">0</td><td valign="bottom">14.57</td><td valign="bottom"><bold>4.52</bold></td></tr><tr><td valign="top">Pine-Oil Disinfectant-Reduced-Susceptibility (<xref ref-type="bibr" rid="bib44">Lamichhane-Khadka et al., 2008</xref>)</td><td valign="bottom">17</td><td valign="bottom">5</td><td valign="bottom">36.4</td><td valign="bottom">23.6</td><td valign="bottom">3.76</td><td valign="bottom">1.70</td><td valign="bottom"><bold>4.44</bold></td></tr><tr><td valign="top">Total</td><td colspan="2" valign="bottom">275</td><td colspan="2" valign="bottom">2093.5</td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr></tbody></table></table-wrap><p>Previously, we identified a truncating mutation in the transcriptional regulator <italic>rsp</italic> to be the most likely candidate for involvement in the progression to infection in one long-term nasal carrier (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>). Although we observed just one variant in <italic>rsp</italic> among the 105 patients (3.9-fold enrichment, p=0.27), we found it was a non-synonymous B-class variant resulting in an alanine to proline substitution in the regulator’s helix-turn-helix DNA binding domain. In separately published experiments (<xref ref-type="bibr" rid="bib12">Das et al., 2016</xref>), we demonstrated that this and the original mutation induce similar loss-of-function phenotypes which, like <italic>agr</italic> loss-of-function mutants, express reduced cytotoxicity, but maintained an ability to persist, disseminate and cause abscesses in vivo.</p><p>We found no significant enrichments of protein-altering variants among D-class variants, but we observed a significant excess of six protein-altering C-class variants in <italic>pbp2</italic> which encodes a penicillin binding protein involved in cell wall synthesis (19.0-fold enrichment, p=10<sup>–6.0</sup>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Pbp2 is an important target of β-lactam antibiotics (<xref ref-type="bibr" rid="bib53">Łeski and Tomasz, 2005</xref>), revealing adaption – potentially in response to antibiotic treatment – in the nose populations of some patients.</p></sec><sec id="s2-4"><title>Genes modulated by virulence regulators and antimicrobial peptides show adaptive evolution between colonizing and infecting bacteria</title><p>To improve the sensitivity to identify adaptive evolution associated with infection, we developed a gene set enrichment analysis (GSEA) approach in which we tested for enrichments of protein-altering B-class variants among groups of genes. GSEA allowed us to detect signatures of adaptive evolution in groups of related genes that were not apparent when interrogating individual genes.</p><p>We grouped genes in two different ways: by gene ontology and by expression pathway. First, we obtained a gene ontology for the reference genome from BioCyc (<xref ref-type="bibr" rid="bib5">Caspi et al., 2016</xref>), which classifies genes into biological processes, cellular components and molecular functions. There were 552 unique gene ontology groupings of two or more genes. We tested for an enrichment among genes belonging to the ontology, compared to the rest of the genes.</p><p>Second, we obtained 248 unique expression pathways from the SAMMD database of transcriptional studies (<xref ref-type="bibr" rid="bib62">Nagarajan and Elasri, 2007</xref>). For each expression pathway, genes were classified as up-regulated, down-regulated or not differentially regulated in response to experimentally manipulated growth conditions or expression of a regulatory gene. For each expression pathway, we tested for an enrichment in genes that were up- or down-regulated compared to genes not differentially regulated.</p><p>The most significant enrichment for protein-altering B-class variants between nose and infection sites occurred in the group of genes down-regulated by the cationic antimicrobial peptide (CAMP) ovispirin-1 (p=10<sup>–7.8</sup>), with a similar enrichment in genes down-regulated by temporin L exposure (p=10<sup>–6.9</sup>, <xref ref-type="fig" rid="fig2">Figure 2C</xref>). Like human CAMPs, the animal-derived ovispirin and temporin compounds inhibit epithelial infections by killing phagocytosed bacteria and mediating inflammatory responses (<xref ref-type="bibr" rid="bib65">Pietiäinen et al., 2009</xref>). In response to inhibitory levels of ovispirin and temporin, <italic>agr</italic>, surface-expressed adhesins and secreted toxins are all down-regulated. Collectively, down-regulated genes showed 2.7-fold and 2.8-fold enrichments of adaptive evolution, respectively. Conversely, genes up-regulated in response to CAMPs, including the <italic>vraSR</italic> and <italic>vraDE</italic> cell-wall operons and stress response genes (<xref ref-type="bibr" rid="bib65">Pietiäinen et al., 2009</xref>), exhibited 0.4-fold and 0.7-fold enrichments (i.e. depletions), respectively (<xref ref-type="table" rid="table3">Table 3</xref>). Thus, expression of the genes undergoing adaptive evolution is strongly inhibited in vitro by host-derived antimicrobial peptides.</p><p>Genes belonging to the cell wall ontology showed the second most significant enrichment for adaptive evolution (p=10<sup>–7.0</sup>). Genes contributing to this 5.0-fold enrichment included the immunoglobulin-binding <italic>S. aureus</italic> Protein A (<italic>spa</italic>), the serine rich adhesin for platelets (<italic>sasA</italic>), clumping factors A and B (<italic>clfA, clfB</italic>), fibronectin binding protein A (<italic>fnbA</italic>) and bone sialic acid binding protein (<italic>bbp</italic>). The latter four genes contributed to another statistically significant 6.4-fold enrichment of adaptive protein evolution in the cell adhesion ontology (p=10<sup>–6.5</sup>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). Therefore, there is a general enrichment of surface-expressed host-binding antigens undergoing adaptive evolution.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.30637.011</object-id><label>Figure 3.</label><caption><title>All genes contributing to the pathways and ontologies most significantly enriched for protein-altering substitutions between nose-colonizing and infection-causing bacteria.</title><p>The pathogenesis ontology, in which significant enrichments were observed in infection-causing but not nose-colonizing bacteria, is shown for comparison. Every gene with at least one substitution between nose-colonizing and infection-causing bacteria and which was up- (red) or down- regulated (blue) in one of the pathways or a member of one of the ontologies (blue) is shown. To the left, the number of altering (yellow/orange) and truncating (pink/red) B-class variants is shown, broken down by the population in which the mutant allele was found: nose (B<sub>C</sub>; yellow/pink) or infection site (B<sub>D</sub>; orange/red).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30637.012</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Genes enriched for substitutions between nose-colonizing and infection-causing bacteria within patients are not the most rapidly evolving at the species level.</title><p>An estimate of the <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> ratio between unrelated bacteria is shown for each gene, color-coded by the number of protein-altering substitutions between nose-colonizing and infection-causing bacteria within patients. There was a negative Spearman rank correlation between <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> ratio and substitutions within patients (<italic>ρ</italic> = –0.04, p=0.02).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30637-fig3-figsupp1-v1"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30637.013</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Gene set enrichment analysis is robust to species-level differences in <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> between genes.</title><p>For every locus, expression pathway and gene ontology, we estimated <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> between unrelated <italic>S. aureus</italic>. There was no relationship between <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> and enrichment of protein-altering substitutions between nose-colonizing and infection-causing bacteria in (<bold>A</bold>) loci, (<bold>B</bold>) ontologies nor (<bold>C</bold>) pathways (non-significant correlations, p&gt;0.05). When we incorporated variability in <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> between genes in the gene set enrichment analyses, the results were robust for (<bold>D</bold>) loci, (<bold>E</bold>) ontologies and (<bold>F</bold>) pathways, showing only small differences in significance (-log<sub>10</sub> <italic>p</italic>-value) between the analyses that correct for locus length only (horizontal axes) and those that correct for locus length and <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> (vertical axes).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30637-fig3-figsupp2-v1"/></fig></fig-group><p>The <italic>rsp</italic> regulon showed the most significant enrichment among gene sets defined by response to individual bacterial regulators (p=10<sup>–6.4</sup>). Genes down-regulated by <italic>rsp</italic> in exponential phase (<xref ref-type="bibr" rid="bib46">Lei et al., 2011</xref>), including surface antigens and the urease operon, exhibited a 3.6-fold enrichment for adaptive evolution, while up-regulated genes showed 0.6-fold enrichment. So whereas <italic>rsp</italic> loss-of-function mutants were rare per se, genes up-regulated in such mutants were hotspots of within-patient adaptation in infected patients. Since expression is a prerequisite for adaptive protein evolution, this implies there are alternative routes by which genes down-regulated by intact <italic>rsp</italic> can be expressed and thereby play an important role within patients other than direct inactivation of <italic>rsp</italic>.</p><p>Loss-of-function in <italic>agr</italic> mutants represent one alternative route, since they exhibit similar phenotypes to <italic>rsp</italic> mutants, with reduced cytotoxicity and increased surface antigen expression, albeit reduced ability to form abscesses (<xref ref-type="bibr" rid="bib12">Das et al., 2016</xref>). We found significant enrichments of genes regulated by <italic>agrA</italic> in two different backgrounds (p&lt;10<sup>–4.5</sup>) and by <italic>sarA</italic> (p=10<sup>–4.6</sup>), underlining the influence of adaptive evolution on both secreted and surface-expressed proteins during infection. We found that expression of genes enriched for protein-altering substitutions was also altered in strains possessing reduced susceptibility to vancomycin, although not in a consistent direction across strains (p&lt;10<sup>–4.7</sup>), and to pine-oil disinfectant (p=10<sup>–4.4</sup>), suggesting such genes may be generally involved in response to harsh environments. All significant signals of enrichment produced neutrality indices exceeding one, consistent with adaptive evolution (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><p>Several genes contributed to multiple evolutionary signals, particularly cell-wall anchored proteins involved in adhesion, the infection process and immune evasion (<xref ref-type="bibr" rid="bib22">Foster et al., 2013</xref>), including <italic>fnbA</italic>, <italic>clfA</italic>, <italic>clfB</italic>, <italic>sasA</italic> and <italic>spa</italic>. These multifactorial, partially overlapping signals suggest a large target for selection in adapting to the within-patient environment (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The fact that we observed no comparable significant enrichments in C-class and D-class protein-altering variants (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) indicates that these evolutionary patterns are associated specifically with the infection process.</p></sec><sec id="s2-5"><title>Adaptive evolution in pathogenesis genes is found only in infecting bacteria</title><p>Having identified adaptive evolution differentiating nose-colonizing and infection-causing bacteria, we next asked whether the mutant alleles were preferentially found in the nose or infection site. We used 1149 sequences from other patients or carriers (Reference Panel II) to reconstruct the genotype of the MRCA of nose-colonizing and infecting bacteriain each patient, respectively. This allowed us to sub-classify B-class variants by whether the mutant allele was found in the nose-colonizing bacteria (B<sub>C</sub>-class) or the disease-causing infection site bacteria (B<sub>D</sub>-class).</p><p><italic>A priori</italic>, we had expected the enrichments of adaptive evolution to be driven primarily by mutants occurring in the infection-causing bacteria (B<sub>D</sub>-class). One group of genes showed a signal of such an enrichment among B<sub>D</sub>-class variants specifically. Genes belonging to the BioCyc pathogenesis ontology were marginally genome-wide significant in B<sub>D</sub>-class variants, showing a 3.1-fold enrichment (p=10<sup>–4.6</sup>) and a statistically insignificant 1.7-fold enrichment in B<sub>C</sub>-class variants (p=0.13). B<sub>D</sub>-class mutants driving this differential signal arose in toxins including gamma hemolysin and several regulatory loci implicated in toxicity and virulence regulation: <italic>rot</italic>, <italic>sarS</italic> and <italic>saeR</italic>.</p><p>Surprisingly, however, we found that all other significantly enriched gene sets were driven by mutant alleles occurring both in nose-colonizing and infecting bacteria (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). This indicates there are common selection pressures in the nose and infection site during the process of infection within patients, leading to convergent evolution across body sites. So while adaptation in pathogenesis genes appears specifically infection-associated, other signals of adaptation in severely infected patients are driven by selection pressures, which might compensate for an altered within-host environment during infection, that are as likely to favor mutants in nose-colonizing bacteria as infecting bacteria.</p></sec><sec id="s2-6"><title>Signals of adaptation are specific to infected patients and differ from prevailing signatures of selection</title><p>Two lines of evidence show that the newly discovered signatures of within-host adaptive evolution, both in infecting and nose-colonizing bacteria, are unique to evolution in infected patients. To test this theory against the alternative explanation that our approach merely detects the most rapidly evolving proteins, we searched for similar signals in alternative settings: evolution within asymptomatic carriers, and species-level evolution between unrelated bacteria.</p><p>There was no significant enrichment of protein-altering variants in any gene, ontology or pathway among 235 variants identified from 10 longitudinally sampled asymptomatic nasal carriers (Reference Panel III, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). To address the modest sample size, we performed goodness-of-fit tests, focusing on the signals most significantly enriched in patients. We found significant depletions of protein-altering variants in carriers relative to patients in the <italic>rsp</italic>, <italic>agr</italic> and <italic>sarA</italic> regulons (p=10<sup>–4.0</sup>) and the pathogenesis ontology (p=10<sup>–3.2</sup>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>).</p><p>Nor were the relative rates of non-synonymous to synonymous substitution (<italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic>) higher between unrelated <italic>S. aureus</italic> (Reference Panel IV) in the genes that contributed most to the signals associated with adaptation within patients: <italic>agrA</italic>, <italic>agrC clfA</italic>, <italic>clfB</italic>, <italic>fnbA</italic> and <italic>sasA</italic>. Although synonymous diversity was somewhat higher than typical in these genes, the <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> ratios showed no evidence for excess protein-altering change in these compared to other genes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Accordingly, incorporating this locus-specific variability of <italic>d<sub>N</sub></italic>/<italic>d<sub>S</sub></italic> into the GSEA did not affect the results (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Taken together these lines of evidence show that the ontologies, pathways and genes significantly differentiated between nose-colonizing and infecting bacteria arise in response to selection pressures specifically associated with infected patients, and are not repeated in asymptomatic carriers or species-level evolution.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We found that common, life-threatening infections of <italic>S. aureus</italic> are frequently descended from commensal bacteria colonizing the nose. These infections are associated with repeatable patterns of bacterial evolution driven by within-patient mutation and selection. Genes involved in pathogenesis, notably toxins and regulators, showed evidence for adaptation in infecting but not nose-colonizing bacteria. Surprisingly, other signatures of adaptation occurred in parallel in nose-colonizing and infecting bacteria, affecting genes responding to cationic antimicrobial peptides and the virulence regulators <italic>rsp</italic> and <italic>agr</italic>. Such genes mediate toxin production, abscess formation, immune evasion and bacterial-host binding. Adaptation within both regulator and effector genes reveals that multiple, alternative evolutionary paths are targeted by selection in infected patients.</p><p>The signatures of within-patient adaptation that we found differed from prevailing signals of selection at the species level. This discordance means that infection-associated adaptive mutations within patients are rarely transmitted, and argues against a straightforward host-pathogen arms race as the predominant evolutionary force acting within and between patients. Instead, it supports the notion of a life-history trade-off between adaptations favoring colonization and infection distinct from those favoring dissemination and onward transmission (<xref ref-type="bibr" rid="bib79">Shopsin et al., 2010</xref>). Infection of this sort can be characterized in terms of an ecological source-sink model, in which commensal bacteria provide the source for potentially life-threatening infections (<xref ref-type="bibr" rid="bib81">Sokurenko et al., 2006</xref>). Ultimately, the short-term survival advantage gained by infecting bacteria, analogous to the short-term advantage of cancerous cells derived from the host, may lead to the demise of both the host and pathogen, epitomizing a tragedy of the commons (<xref ref-type="bibr" rid="bib71">Rankin et al., 2007</xref>). As such, infection may represent an ever-present risk of mutation among commensal bacteria favored by short-term selection but ultimately incidental or damaging to the bacterial reproductive life cycle.</p><p>We did not observe analogous signatures of bacterial adaptation and excess loss-of-function mutations in healthy nose carriers, indicating that risk factors for infections, such as a weakened or over-activated immunological response, comorbidities or medical interventions, may play an important role in creating distinctive selection pressures in infected patients. The effects of such risk factors may be mediated, at least in part, through the selection pressure they exert on commensal bacteria.</p><p>The existence of signatures of adaptive substitutions associated with infection raises the possibility of developing new diagnostic techniques and personalizing treatment to the individual patient’s commensal bacteria. The ability of genomics to characterize the selective forces driving adaption within the human body in unprecedented detail provides new opportunities to improve experimental models of infection. Ultimately, it may be possible to develop therapies that utilize our new understanding of within-patient evolution to target the root causes of infection from the bacterial perspective.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Patient sample collection</title><p>105 patients with severe <italic>S. aureus</italic> infections for whom the organism could be cultured from both admission screening nasal swab and clinical sample were identified prospectively from the microbiological laboratories of hospitals in Oxford and Brighton, England. This study design builds in robustness to potential confounders by matching infection-causing and nose-colonizing bacteria within the same patients. Clinical samples comprised 55 blood cultures and 50 pus, soft tissue, bone or joint samples. The bacteria sampled and sequenced from one patient (‘patient S’, P005 in this study) have been previously described (<xref ref-type="bibr" rid="bib12">Das et al., 2016</xref>). Five individuals had both blood and another culture-positive clinical sample; we focus analysis on the blood sample. Nasal swabs were incubated in 5% NaCl broth overnight at 37C, then streaked onto SASelect agar (BioRad) and incubated overnight at 37C. We picked five colonies per sample (12 during the pilot phase involving 9 patients), streaked each onto Columbia blood agar and incubated overnight at 37C for DNA extraction. Clinical samples were handled according to the local laboratory standard operating procedure for pus, sterile site and blood cultures. When bacterial growth was confirmed as <italic>S. aureus</italic>, the primary culture plate was retrieved, and multiple colonies were picked. These were streaked onto Columbia blood agar and incubated overnight at 37C for DNA extraction.</p></sec><sec id="s4-2"><title>Power calculation for within-patient sample sizes</title><p>Sequencing multiple colonies per site allowed us to distinguish genuine genetic substitutions between nose-colonizing and infection-causing bacteria from polymorphic variants restricted to the nose-colonizing or infection-causing bacteria respectively. Following previous studies of within-host <italic>S. aureus</italic> evolution that we conducted (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>) and the initial pilot phase in which we sequenced 12 colonies per site, we chose to continue with five colonies per site as a compromise between power to distinguish within-site polymorphisms from true between-site substitutions and the cost of whole genome sequencing. Under a standard neutral model with low mutation rate, five colonies per sample is expected to confer 91% power to correctly distinguish within-site polymorphisms from between-site substitutions, compared to 0% power with one colony per sample. The power calculation is<disp-formula id="equ1"><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>n</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo form="prefix" movablelimits="true">Pr</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo form="prefix" movablelimits="true">Pr</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo form="prefix" movablelimits="true">Pr</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>f</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo form="prefix" movablelimits="true">Pr</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>f</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>f</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mi>f</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mi>f</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>where <italic>i</italic> and <italic>f</italic> are the observed sample count and unobserved frequency of a mutant allele in a particular site, <italic>n</italic> is the sample size, and random sampling is assumed. The frequency distribution of a neutral mutant allele, <inline-formula><mml:math id="inf1"><mml:mi>p</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula>, is derived in (<xref ref-type="bibr" rid="bib76">Sawyer et al., 1992</xref>). If the population were expanding, the power would be greater because mutant alleles would be biased yet more toward low frequencies.</p></sec><sec id="s4-3"><title>Reference panels</title><p>For comparison to the patient-derived bacteria, we collated previously described samples from other sources to construct four Reference Panels: I. A collection of 131 genomes capturing cross-sectional diversity in the noses of 13 asymptomatic carriers (<xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>), arising from a carriage study of <italic>S. aureus</italic> in Oxfordshire (<xref ref-type="bibr" rid="bib21">Everitt et al., 2014</xref>) (BioProject PRJEB2881). II. A compilation of 95 unrelated samples from the same Oxfordshire carriage study (BioProject accession number PRJEB5225), 145 sequences from a study of within-host evolution of <italic>S. aureus</italic> in three individuals (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>) (BioProject PRJEB2862) and 909 sequences from nasal carriage and bloodstream infection used in a study of whole genome sequencing to predict antimicrobial resistance (<xref ref-type="bibr" rid="bib29">Gordon et al., 2014</xref>) (BioProject PRJEB5261). We used these samples to improve our reconstruction of ancestral genotypes in each patient. III. A collection of 237 genomes from longitudinal samples from 10 patients (<xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>; <xref ref-type="bibr" rid="bib28">Gordon et al., 2017</xref>), (BioProject PRJNA380544) arising from the same Oxfordshire carriage study. We used these to compare evolution within patients and asymptomatic carriers. IV. A collection of 16 previously published high-quality closed reference genomes, comprising unrelated isolates mainly of clinical and animal origin: MRSA252 (Genbank accession number BX571856.1), MSSA476 (BX571857.1), COL (CP000046.1), NCTC 8325 (CP000253.1), Mu50 (BA000017.4), N315 (BA000018.3), USA300_FPR3757 (CP000255.1), JH1 (CP000736.1), Newman (AP009351.1), TW20 (FN433596.1), S0385 (AM990992.1), JKD6159 (CP002114.2), RF122 (AJ938182.1), ED133 (CP001996.1), ED98 (CP001781.1), EMRSA15 (HE681097.1) (<xref ref-type="bibr" rid="bib33">Holden et al., 2004</xref>; <xref ref-type="bibr" rid="bib25">Gill et al., 2005</xref>; <xref ref-type="bibr" rid="bib26">Gillaspy, 2006</xref>; <xref ref-type="bibr" rid="bib41">Kuroda et al., 2001</xref>; <xref ref-type="bibr" rid="bib16">Diep et al., 2006</xref>; <xref ref-type="bibr" rid="bib2">Baba et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Holden et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Schijffelen et al., 2010</xref>; <xref ref-type="bibr" rid="bib9">Chua et al., 2010</xref>; <xref ref-type="bibr" rid="bib32">Herron-Olson et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Guinane et al., 2010</xref>; <xref ref-type="bibr" rid="bib50">Lowder et al., 2009</xref>; <xref ref-type="bibr" rid="bib34">Holden et al., 2013</xref>). We used these to contrast species-level evolution to within-patient evolution.</p></sec><sec id="s4-4"><title>Whole genome sequencing</title><p>For each bacterial colony, DNA was extracted from the subcultured plate using a mechanical lysis step (FastPrep; MPBiomedicals, Santa Ana, CA) followed by a commercial kit (QuickGene; Fujifilm, Tokyo, Japan), and sequenced at the Wellcome Trust Centre for Human Genetics, Oxford on the Illumina (San Diego, CA) HiSeq 2000 platform, with paired-end reads 101 base pairs for nine patients in the pilot phase, and 150 bases in the remainder. We sequenced 62 genomes in duplicate, a technical replication rate of 5.1%; no genetic discordancies were detected within duplicates.</p></sec><sec id="s4-5"><title>Variant calling</title><p>We used Velvet (<xref ref-type="bibr" rid="bib91">Zerbino and Birney, 2008</xref>) to assemble reads into contigs de novo, and Stampy (<xref ref-type="bibr" rid="bib52">Lunter and Goodson, 2011</xref>) to map reads against two reference genomes: MRSA252 (<xref ref-type="bibr" rid="bib33">Holden et al., 2004</xref>) and a patient-specific reference comprising the contigs assembled for one colony sampled from each patient’s nose. Repetitive regions, defined by BLASTing (<xref ref-type="bibr" rid="bib1">Altschul et al., 1990</xref>) the reference genome against itself, were masked prior to variant calling. To obtain multilocus sequence types (<xref ref-type="bibr" rid="bib20">Enright et al., 2000</xref>), we used BLAST to find the relevant loci, and looked up the nucleotide sequences in the online database at <ext-link ext-link-type="uri" xlink:href="http://saureus.mlst.net/.">http://saureus.mlst.net/.</ext-link></p><p>Bases called at each position in the reference and those passing previously described (<xref ref-type="bibr" rid="bib90">Young et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Didelot et al., 2012</xref>) quality filters were used to identify single nucleotide polymorphisms (SNPs) from Stampy-based mapping to MRSA252 and the patient-specific reference genomes. We used Cortex (<xref ref-type="bibr" rid="bib38">Iqbal et al., 2012</xref>) to identify SNPs and short indels. Variants found by Cortex were excluded if they had fewer than ten supporting reads or if the base call was heterozygous at more than 5% of reads.</p><p>Where physically clustered variants with the same pattern of presence/absence across genomes were found, these were considered likely to represent a single evolutionary event: tandem repeat mutation or recombination. These were de-duplicated to a single variant to avoid inflating evidence of evolutionary events in these regions.</p></sec><sec id="s4-6"><title>Variant annotation and phylogenetic classification</title><p>Maximum likelihood trees were built to infer bacterial relationships within patients (<xref ref-type="bibr" rid="bib31">Gusfield, 1991</xref>). To prioritize variants for further analysis, they were classified according to their phylogenetic position in the tree: B-class (between nose colonization and infection site), C-class (within nose-colonizing population) and D-class (within infection site population). Variants were cross-classified by their predicted functional effect based on mapping to the reference genome or BLASTing to a reference allele: synonymous, non-synonymous or truncating for protein-coding sequences, or non-coding.</p><p>Where variation was found using a patient-specific reference, these variants were annotated by first aligning to MRSA252 using Mauve (<xref ref-type="bibr" rid="bib11">Darling et al., 2004</xref>). If no aligned position in MRSA252 could be found, additional annotated references were used. Where variation was found using Cortex only, the variant was annotated by first locating it by comparing the flanking sequence to MRSA252 and other annotated references using BLAST. MRSA252 orthologs were identified using geneDB (<xref ref-type="bibr" rid="bib49">Logan-Klumpler et al., 2012</xref>) and KEGG (<xref ref-type="bibr" rid="bib39">Kanehisa et al., 2016</xref>).</p></sec><sec id="s4-7"><title>Reconstructing ancestral genotypes per patient</title><p>We constructed a species-level phylogeny for all bacteria sampled from the 105 patients together with Reference Panel II (unrelated asymptomatic nose-colonization isolates and bloodstream infection isolates) using a two-step neighbor-joining and maximum likelihood approach, based on a whole-genome alignment derived from mapping all genomes to MRSA252. We first clustered individuals into seven groups using neighbour-joining (<xref ref-type="bibr" rid="bib74">Saitou and Nei, 1987</xref>), before resolving the relationships within each cluster by building a maximum likelihood tree using RAxML (<xref ref-type="bibr" rid="bib82">Stamatakis, 2014</xref>), assuming a general time reversible (GTR) model. To overcome a limitation in the presence of divergent sequences whereby RAxML fixes a minimum branch length that may be longer than a single substitution event, we fine-tuned the estimates of branch lengths using ClonalFrameML (<xref ref-type="bibr" rid="bib15">Didelot and Wilson, 2015</xref>). We used these subtrees to identify, for each patient, the most closely related ‘nearest neighbor’ sampled from another patient or carrier. We employed this nearest neighbor as an outgroup, and used the tree to reconstruct the sequence of the MRCA of colonizing and infecting bacteria for each patient using a maximum likelihood method (<xref ref-type="bibr" rid="bib68">Pupko et al., 2000</xref>) in ClonalFrameML (<xref ref-type="bibr" rid="bib15">Didelot and Wilson, 2015</xref>). This in turn allowed us to identify the ancestral (wild type) and derived (mutant) allele for all variants mapping to MRSA252. For variants not mapping to MRSA252, we repeated the Cortex variant calling analysis, this time including the nearest neighbor, and identified the ancestral allele as the one possessed by the nearest neighbor. This approach allowed us to identify ancestral (wild type) versus derived (mutant) alleles for 97% of within-patient variants. We used the reconstructions of the within-patient MRCA sequences and identity of ancestral vs derived alleles to sub-categorize B-class variants into those in which the mutant allele was found in the nose-colonizing population (B<sub>C</sub>-class) versus the infection-causing population (B<sub>D</sub>-class). 521 (97%) of B-class variants were typeable, and in 281 (54%) of these, the mutant allele was found in the infection site population. This allowed us to test for differential enrichments in these two sub-classes.</p></sec><sec id="s4-8"><title>Mean pairwise genetic diversity</title><p>Separately for the nose site and infection site of each patient, we calculated the mean pairwise diversity <italic>π</italic> as the mean number of variants differing between each pair of genomes. We compared the distributions of <italic>π</italic> between patients and Reference Panel II (13 cross-sectionally sampled asymptomatic nose carriers) using a Mann-Whitney-Wilcoxon test.</p></sec><sec id="s4-9"><title>Calculating d<sub>N</sub>/d<sub>S</sub> ratio</title><p>For assessing the <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio within patients, we adjusted the ratio of raw counts of total numbers of non-synonymous and synonymous SNPs by the ratio expected under strict neutrality. We estimated that the rate of non-synonymous mutation was 4.9 times higher than that of synonymous mutation in <italic>S. aureus</italic> based on codon usage in MRSA252 and the observed transition:transversion ratio in non-coding SNPs.</p></sec><sec id="s4-10"><title>The neutrality index</title><p>To compare the relative <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratios between two groups of variants we computed a Neutrality Index as <italic>R</italic><sub>1</sub>/<italic>R</italic><sub>2</sub> where <italic>R</italic><sub>1</sub> and <italic>R</italic><sub>2</sub> were the ratio of counts of non-synonymous to synonymous variants in each group respectively (<xref ref-type="bibr" rid="bib58">McDonald and Kreitman, 1991</xref>; <xref ref-type="bibr" rid="bib70">Rand and Kann, 1996</xref>). We compared B-, C- and D-class variants within patients to C-class patients within Reference Panel I (13 cross-sectionally sampled asymptomatic carriers). A Neutrality Index in excess of one indicates a higher <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio in the former group. We used Fisher’s exact test to evaluate the significance of the differences between the groups.</p></sec><sec id="s4-11"><title>Gene enrichment analysis</title><p>To test for significant enrichment of variants in a particular gene, we employed a Poisson regression in which we modelled the expected numbers of de novo variants across patients in any gene <italic>j</italic> as <italic>λ</italic><sub>0</sub><italic>L<sub>j</sub></italic> under the null hypothesis of no enrichment, where <italic>λ</italic><sub>0</sub> gives the expected number of variants per kilobase and <italic>L<sub>j</sub></italic> is the length of gene <italic>j</italic> in kilobases. We compared this to the alternative hypothesis in which the expected number of variants was <italic>λ<sub>i</sub>L<sub>i</sub></italic> for gene <italic>i</italic>, the gene of interest, and <italic>λ</italic><sub>1</sub><italic>L<sub>j</sub></italic> for any other gene <italic>j</italic>. Using R (<xref ref-type="bibr" rid="bib69">R Core Team, 2015</xref>), we estimated the parameters <italic>λ</italic><sub>0</sub>, <italic>λ</italic><sub>1</sub> and <italic>λ<sub>i</sub></italic> from the data by maximum likelihood and tested for significance via a likelihood ratio test with one degree of freedom. This procedure assumes no recombination within patients, which was reasonable since we found little evidence of recombination in this study or previously (<xref ref-type="bibr" rid="bib27">Golubchik et al., 2013</xref>), including no within-host genetic incompatibilities, and we removed physically clustered variants associated with possible recombination events. We analyzed all protein-coding genes in MRSA252, testing for an enrichment of variants expected to alter the transcribed protein (both non-synonymous and truncating mutations). These tests were also applied to synonymous mutations and no enrichments were found.</p></sec><sec id="s4-12"><title>Gene set enrichment analysis</title><p>Since the number of genes outweighed the number of variants detected, we had limited power to detect weak to modest enrichments at the individual gene level. Instead we pooled genes using ontologies from the BioCyc MRSA252 database (<xref ref-type="bibr" rid="bib5">Caspi et al., 2016</xref>) and expression pathways from the SAMMD database of transcriptional studies (<xref ref-type="bibr" rid="bib62">Nagarajan and Elasri, 2007</xref>). The BioCyc database comprises ontologies describing biological processes, cellular components and molecular functions. The SAMMD database groups genes up-regulated, down-regulated or not differentially regulated in response to experimentally manipulated growth conditions or isogenic mutations, usually of a regulatory gene. After excluding ontologies or pathways with two groups, one involving a single gene, and combining ontologies or pathways with identical groupings of genes, we conducted 800 GSEAs in addition to the 2650 ontologies comprised of individual loci. The number of groupings of genes was always two for BioCyc (included/excluded from the ontology) and two or three for SAMMD (up-/down-/un-differentially regulated in the experiment). Again we employed a Poisson regression in which we modelled the expected numbers of variants in any gene <italic>j</italic> as <italic>λ</italic><sub>0</sub><italic>L<sub>j</sub></italic> under the null hypothesis of no enrichment where <italic>λ</italic><sub>0</sub> gives the expected number of variants per kilobase and <italic>L<sub>j</sub></italic> is the length of gene <italic>j</italic> in kilobases. We compared this to the alternative hypothesis in which the expected number of variants was <italic>λ</italic><sub>1</sub><italic>L<sub>j</sub></italic>, <italic>λ</italic><sub>2</sub><italic>L<sub>j</sub></italic> or <italic>λ</italic><sub>3</sub><italic>L<sub>j</sub></italic> for gene <italic>j</italic> depending on the grouping in the ontology/pathway. Using R, we estimated the parameters <italic>λ</italic><sub>0</sub>, <italic>λ</italic><sub>1</sub>, <italic>λ</italic><sub>2</sub> and <italic>λ</italic><sub>3</sub> from the data by maximum likelihood and tested for significance via a likelihood ratio test with one or two degrees of freedom, depending on the number of groupings in the ontology/pathway.</p></sec><sec id="s4-13"><title>GSEA multiple testing correction</title><p>To account for the multiplicity of testing, we adjusted the p-value significance thresholds from a nominal <italic>α</italic> = 0.05 using the weighted Bonferroni method. We weighted the significance thresholds by the relative number of tests in each category: 2650 genes, 552 BioCyc ontologies and 248 SAMMD expression pathways. This avoids overly stringent multiple testing correction in categories with fewer tests (<xref ref-type="bibr" rid="bib73">Roeder and Wasserman, 2009</xref>), for example, the 248 SAMMD expression pathways, owing to other categories with very large numbers of tests, for example, the 2650 genes. This gave adjusted significance thresholds of 10<sup>-5.2</sup> for genes, 10<sup>-4.5</sup> for BioCyc ontologies and 10<sup>-4.2</sup> for SAMMD expression pathways.</p></sec><sec id="s4-14"><title>Longitudinal evolution in asymptomatic carriers</title><p>To test whether the patterns of evolution we observed between colonizing and invading bacteria in severely infected patients were typical or unusual, we analyzed Reference Panel III (a collection of 10 longitudinally sampled asymptomatic carriers). Since natural selection is more efficacious over longer periods of time, the longitudinal sampling of these individuals gave us greater opportunity to detect subtle evolutionary patterns in asymptomatic carriers. We characterized variation in these carriers as in the patients. Given the modest sample size and smaller number of variants detected in these individuals (235), we performed GSEA to test for enrichments only in particular genes, ontologies and pathways that were significantly enriched within patients, requiring less stringent multiple testing correction.</p></sec><sec id="s4-15"><title>omegaMap analysis</title><p>We estimated <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratios between unrelated <italic>S. aureus</italic> to characterize the prevailing patterns of selection at the species level. We used Mauve (<xref ref-type="bibr" rid="bib11">Darling et al., 2004</xref>) to pairwise align 15 reference genomes against MRSA252, that is Reference Panel IV. This allowed us to distinguish orthologs from paralogs in the next step in which we multiply aligned all coding sequences overlapping those in MRSA252 using PAGAN (<xref ref-type="bibr" rid="bib51">Löytynoja et al., 2012</xref>). After removing sequences with premature stop codons, we analyzed each alignment of between two and 16 genes using a modification of omegaMap (<xref ref-type="bibr" rid="bib88">Wilson and McVean, 2006</xref>), assuming all sites were unlinked. We previously showed this assumption, which confers substantial computational efficiency savings, does not adversely affect estimates of selection coefficients (<xref ref-type="bibr" rid="bib87">Wilson et al., 2011</xref>). We estimated variation in <italic>d<sub>N</sub>/d<sub>S</sub></italic> within genes using Monte Carlo Markov chain, running each chain for 10,000 iterations. We assumed exponential prior distributions on the population scaled mutation rate (<italic>θ</italic>), the transition:transversion ratio (<italic>κ</italic>) and the <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio (<italic>ω</italic>) with means 0.05, 3 and 0.2, respectively. We assumed equal codon frequencies and a mean of 30 contiguous codons sharing the same <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio. For each gene, we computed the posterior mean <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio across sites. This allowed us to rank the relative strength of selection across genes in MRSA252, and to account for differences in <italic>d<sub>N</sub>/d<sub>S</sub></italic>, as well as gene length, in the GSEA. We achieved this by modifying the expected number of variants in gene <italic>j</italic> to be <italic>λ</italic><sub>0</sub><italic>ω<sub>j</sub>L<sub>j</sub></italic> under the null hypothesis of no enrichment versus <italic>λ</italic><sub>1</sub><italic>ω<sub>j</sub>L<sub>j</sub></italic>, <italic>λ</italic><sub>2</sub><italic>ω<sub>j</sub>L<sub>j</sub></italic> or <italic>λ</italic><sub>3</sub><italic>ω<sub>j</sub>L<sub>j</sub></italic> under the alternative hypothesis depending on the ontology or pathway, where <italic>ω<sub>j</sub></italic> is the posterior mean <italic>d<sub>N</sub>/d<sub>S</sub></italic> in gene <italic>j</italic>.</p></sec><sec id="s4-16"><title>Ethical framework</title><p>Ethical approval for linking genetic sequences of <italic>S. aureus</italic> isolates to patient data without individual patient consent in Oxford and Brighton in the U.K. was obtained from Berkshire Ethics Committee (10/H0505/83) and the U.K. Health Research Agency [8-05(e)/2010].</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Ed Feil, Stephen Leslie, Gil McVean and Richard Moxon for helpful insights and useful discussions. Sequencing reads uploaded to short read archive (SRA) under BioProject PRJNA369475. RNAseq data relating to isolate from P005 (aka ‘patient S’) previously submitted under BioProject PRJNA279958. The views expressed in this publication are those of the authors and not necessarily those of the funders. This study was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), a Mérieux Research Grant, the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England (PHE) (grant HPRU-2012–10041), and the Health Innovation Challenge Fund (a parallel funding partnership between the Wellcome Trust (grant WT098615/Z/12/Z) and the Department of Health (grant HICF-T5-358)). TEP and DWC are NIHR Senior Investigators. DJW and ZI are Sir Henry Dale Fellows, jointly funded by the Wellcome Trust and the Royal Society (Grants 101237/Z/13/Z and 102541/Z/13/Z). BCY is a Research Training Fellow funded by the Wellcome Trust (Grant 101611/Z/13/Z). We acknowledge the support of Wellcome Trust Centre for Human Genetics core funding (Grant 090532/Z/09/Z).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Study design, Sample collection, DNA extraction, Bioinformatics, Analysis, Writing</p></fn><fn fn-type="con" id="con2"><p>Bioinformatics, Analysis, Writing</p></fn><fn fn-type="con" id="con3"><p>Sample collection, DNA extraction</p></fn><fn fn-type="con" id="con4"><p>DNA extraction</p></fn><fn fn-type="con" id="con5"><p>Sample collection</p></fn><fn fn-type="con" id="con6"><p>DNA extraction</p></fn><fn fn-type="con" id="con7"><p>Bioinformatics</p></fn><fn fn-type="con" id="con8"><p>DNA extraction</p></fn><fn fn-type="con" id="con9"><p>Bioinformatics</p></fn><fn fn-type="con" id="con10"><p>Bioinformatics</p></fn><fn fn-type="con" id="con11"><p>Bioinformatics</p></fn><fn fn-type="con" id="con12"><p>Study design, Interpretation</p></fn><fn fn-type="con" id="con13"><p>Study design, Interpretation</p></fn><fn fn-type="con" id="con14"><p>Study design, Sample collection, Interpretation</p></fn><fn fn-type="con" id="con15"><p>Study design, Sample collection, Interpretation</p></fn><fn fn-type="con" id="con16"><p>Study design, Sample collection, Interpretation</p></fn><fn fn-type="con" id="con17"><p>Study design, Sample collection, Interpretation</p></fn><fn fn-type="con" id="con18"><p>Study design, Sample collection, Interpretation</p></fn><fn fn-type="con" id="con19"><p>Study design, Analysis</p></fn><fn fn-type="con" id="con20"><p>Study design, Analysis, Writing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical approval for linking genetic sequences of S. aureus isolates to patient data without individual patient consent in Oxford and Brighton in the U.K. was obtained from Berkshire Ethics Committee (10/H0505/83) and the U.K. Health Research Agency [8-05(e)/2010].</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.30637.014</object-id><label>Supplementary file 1.</label><caption><title>List of all cultures included in the site, the site of infection (and any known source if bloodstream), number of isolates sequenced from each site, ST or CC by in silico MLST, number of variants found at each site and the mean pair-wise difference comparing isolates.</title></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-30637-supp1-v1.csv"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.30637.015</object-id><label>Supplementary file 2.</label><caption><title>List of all variants found within patients with <italic>S. aureus</italic> infections, location on shared reference (MRSA252), or position and reference genome name and accession number if variant could not be localized on MRSA252.</title><p>Each variant is described by the alleles found, its location in gene, the predicted effect on gene product and the location of the variant on the phylogenetic tree.</p></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-30637-supp2-v1.csv"/></supplementary-material><supplementary-material id="supp3"><object-id pub-id-type="doi">10.7554/eLife.30637.016</object-id><label>Supplementary file 3.</label><caption><title>Neutrality indices show signals of adaptation among the genes, gene ontologies and expression pathways most significantly enriched for protein-altering B-class variants.</title><p>Neutrality indices (NIs, <italic>41,42</italic>) were calculated as the odds ratio of the number of protein-altering to synonymous variants among B-class versus C/D-class variants. These tests are less powerful than the Poisson regression likelihood ratio tests used to detect gene or gene set enrichment of protein-altering B-class variants (<xref ref-type="table" rid="table3">Table 3</xref>); we present them to demonstrate that the direction of enrichment was consistent with adaptation (NI &gt; 1). To mitigate the reduced power, we calculated the expected numbers of protein-altering B-class variants from the numbers of protein-altering C/D-class variants, synonymous B-class variants and synonymous C/D-class variants by pooling them across all genes. This was justified by the absence of evidence for within-patient recombination and lack of enrichment signals among synonymous variants and C/D class protein-altering variants. A one-tailed Poisson test in R (<xref ref-type="bibr" rid="bib69">R Core Team, 2015</xref>) was used to test NI &gt; 1 (significant NIs at p&lt;0.05 in bold).</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-30637-supp3-v1.docx"/></supplementary-material><supplementary-material id="supp4"><object-id pub-id-type="doi">10.7554/eLife.30637.017</object-id><label>Supplementary file 4.</label><caption><title>List of all variants found within long term asymptomatic carriers, location on shared reference (MRSA252), or position and reference genome name and accession number if variant was not localized on MRSA252.</title><p>Each variant is described by the alleles found, its location in gene and the predicted effect on gene product.</p></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-30637-supp4-v1.csv"/></supplementary-material><supplementary-material id="supp5"><object-id pub-id-type="doi">10.7554/eLife.30637.018</object-id><label>Supplementary file 5.</label><caption><title>For all ontologies showing enrichment in within-patient B<sub>D</sub>-class variants, we identified the genes with variants contributing to the signal.</title><p>We counted the number of protein-altering variants in these genes within patients, and compared to the number in long-term asymptomatic carriers. p-Values calculated using Fisher’s exact test. *Variant totals are different for SAMMD pathways (<italic>rsp, agrA, sarA</italic>) and BioCyc ontologies (cell wall, cell adhesion, pathogenesis) because pathway information is available for a different number of loci in each database.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-30637-supp5-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.30637.019</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-30637-transrepform-v1.docx"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following dataset was generated:</p><p><related-object content-type="generated-dataset" id="dataset1" source-id="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA369475" source-id-type="uri"><collab collab-type="author">Bernadette C Young</collab><collab collab-type="author">Chieh-Hsi Wu</collab><collab collab-type="author">N Claire Gordon</collab><collab collab-type="author">James R Price</collab><collab collab-type="author">Kevin Cole</collab><collab collab-type="author">Elian Liu</collab><collab collab-type="author">Anna E Sheppard</collab><collab collab-type="author">Sanuki Perera</collab><collab collab-type="author">Tanya Golubchik</collab><collab collab-type="author">Zamin Iqbal</collab><collab collab-type="author">Rory Bowden</collab><collab collab-type="author">Ruth C Massey</collab><collab collab-type="author">John Paul</collab><collab collab-type="author">Derrick W Crook</collab><collab collab-type="author">Timothy E Peto</collab><collab collab-type="author">A Sarah Walker</collab><collab collab-type="author">Martin J Llewelyn</collab><collab collab-type="author">David H Wyllie</collab><collab collab-type="author">Daniel J Wilson</collab><year>2017</year><source>Illumina Sequencing Data</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA369475">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA369475</ext-link><comment>Publicly available at NCBI BioProject (accession no. PRJNA369475)</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataset6" source-id="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2881" source-id-type="uri"><collab collab-type="author">Tanya Golubchik</collab><collab collab-type="author">Elizabeth M. Batty</collab><collab collab-type="author">Ruth R. Miller</collab><collab collab-type="author">Helen Farr</collab><collab collab-type="author">Bernadette C. Young</collab><collab collab-type="author">Hanna Larner-Svensson</collab><collab collab-type="author">Rowena Fung</collab><collab collab-type="author">Heather Godwin</collab><collab collab-type="author">Kyle Knox</collab><collab collab-type="author">Antonina Votintseva</collab><collab collab-type="author">Richard G. Everitt</collab><collab collab-type="author">Teresa Street</collab><collab collab-type="author">Madeleine Cule</collab><collab collab-type="author">Camilla L. C. Ip</collab><collab collab-type="author">Xavier Didelot</collab><collab collab-type="author">Timothy E. A. Peto</collab><collab collab-type="author">Rosalind M. Harding</collab><collab collab-type="author">Daniel J. Wilson</collab><collab collab-type="author">Derrick W. Crook</collab><collab collab-type="author">Rory Bowden</collab><year>2013</year><source>Reference Panel I</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2881">https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2881</ext-link><comment>Publicly available at NCBI BioProject (accession no. PRJEB2881)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset4" source-id="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB5225" source-id-type="uri"><collab collab-type="author">Richard G. Everitt</collab><collab collab-type="author">Xavier Didelot</collab><collab collab-type="author">Elizabeth M. Batty</collab><collab collab-type="author">Ruth R Miller</collab><collab collab-type="author">Kyle Knox</collab><collab collab-type="author">Bernadette C. Young</collab><collab collab-type="author">Rory Bowden</collab><collab collab-type="author">Adam Auton</collab><collab collab-type="author">Antonina Votintseva</collab><collab collab-type="author">Hanna Larner-Svensson</collab><collab collab-type="author">Jane Charlesworth</collab><collab collab-type="author">Tanya Golubchik</collab><collab collab-type="author">Camilla L. C. Ip</collab><collab collab-type="author">Heather Godwin</collab><collab collab-type="author">Rowena Fung</collab><collab collab-type="author">Tim E. A. Peto</collab><collab collab-type="author">A. Sarah Walker</collab><collab collab-type="author">Derrick W. Crook &amp; Daniel J. Wilson</collab><year>2014</year><source>Reference Panel IIa</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB5225">https://www.ncbi.nlm.nih.gov/bioproject/PRJEB5225</ext-link><comment>Publicly available at NCBI BioProject (accession no. PRJEB5225)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset5" source-id="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2862" source-id-type="uri"><collab collab-type="author">Bernadette C. Young</collab><collab collab-type="author">Tanya Golubchik</collab><collab collab-type="author">Elizabeth Batty</collab><collab collab-type="author">Rowena Fung</collab><collab collab-type="author">Hanna Larner-Svensson</collab><collab collab-type="author">Antonina Votintseva</collab><collab collab-type="author">Ruth Miller</collab><collab collab-type="author">Heather Goodwin</collab><collab collab-type="author">Kyle Knox</collab><collab collab-type="author">Richared Everitt</collab><collab collab-type="author">Zamin Iqbal</collab><collab collab-type="author">Andrew Rimer</collab><collab collab-type="author">Madeline Cule</collab><collab collab-type="author">Camilla Ip</collab><collab collab-type="author">Xavier Didelot</collab><collab collab-type="author">Rosalind Harding</collab><collab collab-type="author">Peter Donnelly</collab><collab collab-type="author">Timothy E Peto</collab><collab collab-type="author">Derrick W Crook</collab><collab collab-type="author">Rory Bowden</collab><collab collab-type="author">Daniel J Wilson</collab><year>2012</year><source>Reference Panel IIb</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2862">https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2862</ext-link><comment>Publicly available at NCBI BioProject (accession no. PRJEB2862)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset3" source-id="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB5261" source-id-type="uri"><collab collab-type="author">N Claire Gordon</collab><collab collab-type="author">JR Price</collab><collab collab-type="author">K Cole</collab><collab collab-type="author">R Everitt</collab><collab collab-type="author">M Morgan</collab><collab collab-type="author">J Finney</collab><collab collab-type="author">AM Kearns</collab><collab collab-type="author">B Pichon</collab><collab collab-type="author">BC Young</collab><collab collab-type="author">DJ Wilson</collab><collab collab-type="author">MJ Llewelyn</collab><collab collab-type="author">J. Paul</collab><collab collab-type="author">TEA. Peto</collab><collab collab-type="author">DW Crooa</collab><collab collab-type="author">AS Walker</collab><collab collab-type="author">T Golubchik</collab><year>2014</year><source>Reference Panel IIc</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB5261">https://www.ncbi.nlm.nih.gov/bioproject/PRJEB5261</ext-link><comment>Publicly available at NCBI BioProject (accession no. PRJEB5261)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset2" source-id="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA380544" source-id-type="uri"><collab collab-type="author">N Claire Gordon</collab><collab collab-type="author">B Pichon</collab><collab collab-type="author">T Golubchik</collab><collab collab-type="author">DJ Wilson</collab><collab collab-type="author">John Paul</collab><collab collab-type="author">DS Blanc</collab><collab collab-type="author">Kevin Cole</collab><collab collab-type="author">J Collins</collab><collab collab-type="author">N Cortes</collab><collab collab-type="author">M Cubbon</collab><collab collab-type="author">FK Gould</collab><collab collab-type="author">PJ Jenks</collab><collab collab-type="author">M Llewelyn</collab><collab collab-type="author">JQ Nash</collab><collab collab-type="author">JM Orendi</collab><collab collab-type="author">K Paranthaman</collab><collab collab-type="author">J Price</collab><collab collab-type="author">L Senn</collab><collab collab-type="author">HL Thomas</collab><collab collab-type="author">S Wyllie</collab><collab collab-type="author">DW Crook</collab><collab collab-type="author">Timothy Peto</collab><collab collab-type="author">AS Walker</collab><collab collab-type="author">AM Kearns</collab><year>2017</year><source>Reference Panel III</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA380544">https://www.ncbi.nlm.nih.gov/bioproject/PRJNA380544</ext-link><comment>Publicly available at NCBI BioProject (accession no. PRJNA380544)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset7" source-id="https://www.ncbi.nlm.nih.gov/nuccore/BX571856.1" source-id-type="uri"><collab collab-type="author">Matthew Holden</collab><year>2004</year><source>Reference Panel IV MRSA252</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/BX571856.1">https://www.ncbi.nlm.nih.gov/nuccore/BX571856.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. BX571856.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset8" source-id="https://www.ncbi.nlm.nih.gov/nuccore/BX571857.1" source-id-type="uri"><collab collab-type="author">Matthew Holden</collab><year>2004</year><source>Reference Panel IV MSSA476</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/BX571857.1">https://www.ncbi.nlm.nih.gov/nuccore/BX571857.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. BX571857.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset9" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP000046.1" source-id-type="uri"><collab collab-type="author">SR Gill</collab><year>2005</year><source>Reference Panel IV COL</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP000046.1">https://www.ncbi.nlm.nih.gov/nuccore/CP000046.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP000046.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset10" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP000253.1" source-id-type="uri"><collab collab-type="author">AF Gillaspy</collab><year>2006</year><source>Reference Panel IV NCTC 8325</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP000253.1">https://www.ncbi.nlm.nih.gov/nuccore/CP000253.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP000253.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset11" source-id="https://www.ncbi.nlm.nih.gov/nuccore/BA000017.4" source-id-type="uri"><collab collab-type="author">M Kuroda</collab><year>2001</year><source>Reference Panel IV Mu50</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/BA000017.4">https://www.ncbi.nlm.nih.gov/nuccore/BA000017.4</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. BA000017.4)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset12" source-id="https://www.ncbi.nlm.nih.gov/nuccore/BA000018.3" source-id-type="uri"><collab collab-type="author">M Kuroda</collab><year>2001</year><source>Reference Panel IV N315</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/BA000018.3">https://www.ncbi.nlm.nih.gov/nuccore/BA000018.3</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. BA000018.3)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset13" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP000255.1" source-id-type="uri"><collab collab-type="author">BA Diep</collab><year>2006</year><source>Reference Panel IV USA300_FPR3757</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP000255.1">https://www.ncbi.nlm.nih.gov/nuccore/CP000255.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP000255.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset14" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP000736.1" source-id-type="uri"><collab collab-type="author">A Copeland</collab><year>2007</year><source>Reference Panel IV JH1</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP000736.1">https://www.ncbi.nlm.nih.gov/nuccore/CP000736.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP000736.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset15" source-id="https://www.ncbi.nlm.nih.gov/nuccore/AP009351.1" source-id-type="uri"><collab collab-type="author">T Baba</collab><year>2008</year><source>Reference Panel IV Newman</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AP009351.1">https://www.ncbi.nlm.nih.gov/nuccore/AP009351.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. AP009351.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset16" source-id="https://www.ncbi.nlm.nih.gov/nuccore/FN433596.1" source-id-type="uri"><collab collab-type="author">Matthew Holden</collab><year>2010</year><source>Reference Panel IV TW20</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/FN433596.1">https://www.ncbi.nlm.nih.gov/nuccore/FN433596.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. FN433596.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset17" source-id="https://www.ncbi.nlm.nih.gov/nuccore/AM990992.1" source-id-type="uri"><collab collab-type="author">MJ Schijffelen</collab><year>2010</year><source>Reference Panel IV S0385</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AM990992.1">https://www.ncbi.nlm.nih.gov/nuccore/AM990992.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. AM990992.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset18" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP002114.2" source-id-type="uri"><collab collab-type="author">K Chua</collab><year>2010</year><source>Reference Panel IV JKD6159</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP002114.2">https://www.ncbi.nlm.nih.gov/nuccore/CP002114.2</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP002114.2)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset19" source-id="https://www.ncbi.nlm.nih.gov/nuccore/AJ938182.1" source-id-type="uri"><collab collab-type="author">Herron-Olson</collab><year>2007</year><source>Reference Panel IV RF122</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AJ938182.1">https://www.ncbi.nlm.nih.gov/nuccore/AJ938182.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. AJ938182.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset20" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP001996.1" source-id-type="uri"><collab collab-type="author">CM Guinane</collab><year>2010</year><source>Reference Panel IV ED133</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP001996.1">https://www.ncbi.nlm.nih.gov/nuccore/CP001996.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP001996.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset21" source-id="https://www.ncbi.nlm.nih.gov/nuccore/CP001781.1" source-id-type="uri"><collab collab-type="author">BV Lowder</collab><year>2009</year><source>Reference Panel IV ED98</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/CP001781.1">https://www.ncbi.nlm.nih.gov/nuccore/CP001781.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. CP001781.1)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset22" source-id="https://www.ncbi.nlm.nih.gov/nuccore/HE681097.1" source-id-type="uri"><collab collab-type="author">Matthew Holden</collab><year>2013</year><source>Reference Panel IV EMRSA15</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/HE681097.1">https://www.ncbi.nlm.nih.gov/nuccore/HE681097.1</ext-link><comment>Publicly available at NCBI Nucleotide (accession no. HE681097.1)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname> <given-names>SF</given-names></name><name><surname>Gish</surname> <given-names>W</given-names></name><name><surname>Miller</surname> <given-names>W</given-names></name><name><surname>Myers</surname> <given-names>EW</given-names></name><name><surname>Lipman</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Basic local alignment search tool</article-title><source>Journal of Molecular Biology</source><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname> <given-names>T</given-names></name><name><surname>Bae</surname> <given-names>T</given-names></name><name><surname>Schneewind</surname> <given-names>O</given-names></name><name><surname>Takeuchi</surname> <given-names>F</given-names></name><name><surname>Hiramatsu</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genome sequence of <italic>Staphylococcus aureus</italic> strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>300</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1128/JB.01000-07</pub-id><pub-id pub-id-type="pmid">17951380</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>SP</given-names></name><name><surname>Cornforth</surname> <given-names>DM</given-names></name><name><surname>Mideo</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control</article-title><source>Trends in Microbiology</source><volume>20</volume><fpage>336</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2012.04.005</pub-id><pub-id pub-id-type="pmid">22564248</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casadevall</surname> <given-names>A</given-names></name><name><surname>Fang</surname> <given-names>FC</given-names></name><name><surname>Pirofski</surname> <given-names>LA</given-names></name><name><surname>Fang, LA Pirofski</surname> <given-names>FC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Microbial virulence as an emergent property: consequences and opportunities</article-title><source>PLoS Pathogens</source><volume>7</volume><elocation-id>e1002136</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002136</pub-id><pub-id pub-id-type="pmid">21814511</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caspi</surname> <given-names>R</given-names></name><name><surname>Billington</surname> <given-names>R</given-names></name><name><surname>Ferrer</surname> <given-names>L</given-names></name><name><surname>Foerster</surname> <given-names>H</given-names></name><name><surname>Fulcher</surname> <given-names>CA</given-names></name><name><surname>Keseler</surname> <given-names>IM</given-names></name><name><surname>Kothari</surname> <given-names>A</given-names></name><name><surname>Krummenacker</surname> <given-names>M</given-names></name><name><surname>Latendresse</surname> <given-names>M</given-names></name><name><surname>Mueller</surname> <given-names>LA</given-names></name><name><surname>Ong</surname> <given-names>Q</given-names></name><name><surname>Paley</surname> <given-names>S</given-names></name><name><surname>Subhraveti</surname> <given-names>P</given-names></name><name><surname>Weaver</surname> <given-names>DS</given-names></name><name><surname>Karp</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D471</fpage><lpage>D480</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1164</pub-id><pub-id pub-id-type="pmid">26527732</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassat</surname> <given-names>J</given-names></name><name><surname>Dunman</surname> <given-names>PM</given-names></name><name><surname>Murphy</surname> <given-names>E</given-names></name><name><surname>Projan</surname> <given-names>SJ</given-names></name><name><surname>Beenken</surname> <given-names>KE</given-names></name><name><surname>Palm</surname> <given-names>KJ</given-names></name><name><surname>Yang</surname> <given-names>SJ</given-names></name><name><surname>Rice</surname> <given-names>KC</given-names></name><name><surname>Bayles</surname> <given-names>KW</given-names></name><name><surname>Smeltzer</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Transcriptional profiling of a <italic>Staphylococcus aureus</italic> clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390</article-title><source>Microbiology</source><volume>152</volume><fpage>3075</fpage><lpage>3090</lpage><pub-id pub-id-type="doi">10.1099/mic.0.29033-0</pub-id><pub-id pub-id-type="pmid">17005987</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>PE</given-names></name><name><surname>Shapiro</surname> <given-names>BJ</given-names></name><name><surname>Chen, BJ Shapiro</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The advent of genome-wide association studies for bacteria</article-title><source>Current Opinion in Microbiology</source><volume>25</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2015.03.002</pub-id><pub-id pub-id-type="pmid">25835153</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chewapreecha</surname> <given-names>C</given-names></name><name><surname>Marttinen</surname> <given-names>P</given-names></name><name><surname>Croucher</surname> <given-names>NJ</given-names></name><name><surname>Salter</surname> <given-names>SJ</given-names></name><name><surname>Harris</surname> <given-names>SR</given-names></name><name><surname>Mather</surname> <given-names>AE</given-names></name><name><surname>Hanage</surname> <given-names>WP</given-names></name><name><surname>Goldblatt</surname> <given-names>D</given-names></name><name><surname>Nosten</surname> <given-names>FH</given-names></name><name><surname>Turner</surname> <given-names>C</given-names></name><name><surname>Turner</surname> <given-names>P</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004547</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004547</pub-id><pub-id pub-id-type="pmid">25101644</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname> <given-names>K</given-names></name><name><surname>Seemann</surname> <given-names>T</given-names></name><name><surname>Harrison</surname> <given-names>PF</given-names></name><name><surname>Davies</surname> <given-names>JK</given-names></name><name><surname>Coutts</surname> <given-names>SJ</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Haring</surname> <given-names>V</given-names></name><name><surname>Moore</surname> <given-names>R</given-names></name><name><surname>Howden</surname> <given-names>BP</given-names></name><name><surname>Stinear</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Complete genome sequence of <italic>Staphylococcus aureus</italic> strain JKD6159, a unique Australian clone of ST93-IV community methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Journal of Bacteriology</source><volume>192</volume><fpage>5556</fpage><lpage>5557</lpage><pub-id pub-id-type="doi">10.1128/JB.00878-10</pub-id><pub-id pub-id-type="pmid">20729356</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>L</given-names></name><name><surname>Lian</surname> <given-names>JQ</given-names></name><name><surname>Neoh</surname> <given-names>HM</given-names></name><name><surname>Reyes</surname> <given-names>E</given-names></name><name><surname>Hiramatsu</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>DNA microarray-based identification of genes associated with glycopeptide resistance in <italic>Staphylococcus aureus</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>49</volume><fpage>3404</fpage><lpage>3413</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.8.3404-3413.2005</pub-id><pub-id pub-id-type="pmid">16048954</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darling</surname> <given-names>AC</given-names></name><name><surname>Mau</surname> <given-names>B</given-names></name><name><surname>Blattner</surname> <given-names>FR</given-names></name><name><surname>Perna</surname> <given-names>NT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mauve: multiple alignment of conserved genomic sequence with rearrangements</article-title><source>Genome Research</source><volume>14</volume><fpage>1394</fpage><lpage>1403</lpage><pub-id pub-id-type="doi">10.1101/gr.2289704</pub-id><pub-id pub-id-type="pmid">15231754</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Lindemann</surname> <given-names>C</given-names></name><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Muller</surname> <given-names>J</given-names></name><name><surname>Österreich</surname> <given-names>B</given-names></name><name><surname>Ternette</surname> <given-names>N</given-names></name><name><surname>Winkler</surname> <given-names>AC</given-names></name><name><surname>Paprotka</surname> <given-names>K</given-names></name><name><surname>Reinhardt</surname> <given-names>R</given-names></name><name><surname>Förstner</surname> <given-names>KU</given-names></name><name><surname>Allen</surname> <given-names>E</given-names></name><name><surname>Flaxman</surname> <given-names>A</given-names></name><name><surname>Yamaguchi</surname> <given-names>Y</given-names></name><name><surname>Rollier</surname> <given-names>CS</given-names></name><name><surname>van Diemen</surname> <given-names>P</given-names></name><name><surname>Blättner</surname> <given-names>S</given-names></name><name><surname>Remmele</surname> <given-names>CW</given-names></name><name><surname>Selle</surname> <given-names>M</given-names></name><name><surname>Dittrich</surname> <given-names>M</given-names></name><name><surname>Müller</surname> <given-names>T</given-names></name><name><surname>Vogel</surname> <given-names>J</given-names></name><name><surname>Ohlsen</surname> <given-names>K</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Massey</surname> <given-names>R</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Rudel</surname> <given-names>T</given-names></name><name><surname>Wyllie</surname> <given-names>DH</given-names></name><name><surname>Fraunholz</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Natural mutations in a <italic>Staphylococcus aureus</italic> virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation</article-title><source>PNAS</source><volume>113</volume><fpage>E3101</fpage><lpage>E3110</lpage><pub-id pub-id-type="doi">10.1073/pnas.1520255113</pub-id><pub-id pub-id-type="pmid">27185949</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Eyre</surname> <given-names>DW</given-names></name><name><surname>Cule</surname> <given-names>M</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Ansari</surname> <given-names>MA</given-names></name><name><surname>Griffiths</surname> <given-names>D</given-names></name><name><surname>Vaughan</surname> <given-names>A</given-names></name><name><surname>O'Connor</surname> <given-names>L</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Piazza</surname> <given-names>P</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Dingle</surname> <given-names>KE</given-names></name><name><surname>Wilcox</surname> <given-names>M</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Harding</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Microevolutionary analysis of <italic>Clostridium difficile</italic> genomes to investigate transmission</article-title><source>Genome Biology</source><volume>13</volume><elocation-id>R118</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2012-13-12-r118</pub-id><pub-id pub-id-type="pmid">23259504</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Within-host evolution of bacterial pathogens</article-title><source>Nature Reviews Microbiology</source><volume>14</volume><fpage>150</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2015.13</pub-id><pub-id pub-id-type="pmid">26806595</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ClonalFrameML: efficient inference of recombination in whole bacterial genomes</article-title><source>PLoS Computational Biology</source><volume>11</volume><elocation-id>e1004041</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004041</pub-id><pub-id pub-id-type="pmid">25675341</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diep</surname> <given-names>BA</given-names></name><name><surname>Gill</surname> <given-names>SR</given-names></name><name><surname>Chang</surname> <given-names>RF</given-names></name><name><surname>Phan</surname> <given-names>TH</given-names></name><name><surname>Chen</surname> <given-names>JH</given-names></name><name><surname>Davidson</surname> <given-names>MG</given-names></name><name><surname>Lin</surname> <given-names>F</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Carleton</surname> <given-names>HA</given-names></name><name><surname>Mongodin</surname> <given-names>EF</given-names></name><name><surname>Sensabaugh</surname> <given-names>GF</given-names></name><name><surname>Perdreau-Remington</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>The Lancet</source><volume>367</volume><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68231-7</pub-id><pub-id pub-id-type="pmid">16517273</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunman</surname> <given-names>PM</given-names></name><name><surname>Murphy</surname> <given-names>E</given-names></name><name><surname>Haney</surname> <given-names>S</given-names></name><name><surname>Palacios</surname> <given-names>D</given-names></name><name><surname>Tucker-Kellogg</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>EL</given-names></name><name><surname>Zagursky</surname> <given-names>RJ</given-names></name><name><surname>Shlaes</surname> <given-names>D</given-names></name><name><surname>Projan</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Transcription profiling-based identification of <italic>Staphylococcus aureus</italic> genes regulated by the agr and/or sarA loci</article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>7341</fpage><lpage>7353</lpage><pub-id pub-id-type="doi">10.1128/JB.183.24.7341-7353.2001</pub-id><pub-id pub-id-type="pmid">11717293</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earle</surname> <given-names>SG</given-names></name><name><surname>Wu</surname> <given-names>CH</given-names></name><name><surname>Charlesworth</surname> <given-names>J</given-names></name><name><surname>Stoesser</surname> <given-names>N</given-names></name><name><surname>Gordon</surname> <given-names>NC</given-names></name><name><surname>Walker</surname> <given-names>TM</given-names></name><name><surname>Spencer</surname> <given-names>CCA</given-names></name><name><surname>Iqbal</surname> <given-names>Z</given-names></name><name><surname>Clifton</surname> <given-names>DA</given-names></name><name><surname>Hopkins</surname> <given-names>KL</given-names></name><name><surname>Woodford</surname> <given-names>N</given-names></name><name><surname>Smith</surname> <given-names>EG</given-names></name><name><surname>Ismail</surname> <given-names>N</given-names></name><name><surname>Llewelyn</surname> <given-names>MJ</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identifying lineage effects when controlling for population structure improves power in bacterial association studies</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>16041</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.41</pub-id><pub-id pub-id-type="pmid">27572646</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eldholm</surname> <given-names>V</given-names></name><name><surname>Norheim</surname> <given-names>G</given-names></name><name><surname>von der Lippe</surname> <given-names>B</given-names></name><name><surname>Kinander</surname> <given-names>W</given-names></name><name><surname>Dahle</surname> <given-names>UR</given-names></name><name><surname>Caugant</surname> <given-names>DA</given-names></name><name><surname>Mannsåker</surname> <given-names>T</given-names></name><name><surname>Mengshoel</surname> <given-names>AT</given-names></name><name><surname>Dyrhol-Riise</surname> <given-names>AM</given-names></name><name><surname>Balloux</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Evolution of extensively drug-resistant <italic>Mycobacterium tuberculosis</italic> from a susceptible ancestor in a single patient</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>490</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0490-3</pub-id><pub-id pub-id-type="pmid">25418686</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enright</surname> <given-names>MC</given-names></name><name><surname>Day</surname> <given-names>NP</given-names></name><name><surname>Davies</surname> <given-names>CE</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Spratt</surname> <given-names>BG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of <italic>Staphylococcus aureus</italic></article-title><source>Journal of Clinical Microbiology</source><volume>38</volume><fpage>1008</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">10698988</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everitt</surname> <given-names>RG</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Miller</surname> <given-names>RR</given-names></name><name><surname>Knox</surname> <given-names>K</given-names></name><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Auton</surname> <given-names>A</given-names></name><name><surname>Votintseva</surname> <given-names>A</given-names></name><name><surname>Larner-Svensson</surname> <given-names>H</given-names></name><name><surname>Charlesworth</surname> <given-names>J</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Godwin</surname> <given-names>H</given-names></name><name><surname>Fung</surname> <given-names>R</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mobile elements drive recombination hotspots in the core genome of <italic>Staphylococcus aureus</italic></article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3956</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4956</pub-id><pub-id pub-id-type="pmid">24853639</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname> <given-names>TJ</given-names></name><name><surname>Geoghegan</surname> <given-names>JA</given-names></name><name><surname>Ganesh</surname> <given-names>VK</given-names></name><name><surname>Höök</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adhesion, invasion and evasion: the many functions of the surface proteins of <italic>Staphylococcus aureus</italic></article-title><source>Nature Reviews Microbiology</source><volume>12</volume><fpage>49</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3161</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>W</given-names></name><name><surname>Chua</surname> <given-names>K</given-names></name><name><surname>Davies</surname> <given-names>JK</given-names></name><name><surname>Newton</surname> <given-names>HJ</given-names></name><name><surname>Seemann</surname> <given-names>T</given-names></name><name><surname>Harrison</surname> <given-names>PF</given-names></name><name><surname>Holmes</surname> <given-names>NE</given-names></name><name><surname>Rhee</surname> <given-names>HW</given-names></name><name><surname>Hong</surname> <given-names>JI</given-names></name><name><surname>Hartland</surname> <given-names>EL</given-names></name><name><surname>Stinear</surname> <given-names>TP</given-names></name><name><surname>Howden</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection</article-title><source>PLoS Pathogens</source><volume>6</volume><elocation-id>e1000944</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000944</pub-id><pub-id pub-id-type="pmid">20548948</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2015 Mortality and Causes of Death Collaborators</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015</article-title><source>Lancet</source><volume>388</volume><fpage>1459</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)31012-1</pub-id><pub-id pub-id-type="pmid">27733281</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname> <given-names>SR</given-names></name><name><surname>Fouts</surname> <given-names>DE</given-names></name><name><surname>Archer</surname> <given-names>GL</given-names></name><name><surname>Mongodin</surname> <given-names>EF</given-names></name><name><surname>Deboy</surname> <given-names>RT</given-names></name><name><surname>Ravel</surname> <given-names>J</given-names></name><name><surname>Paulsen</surname> <given-names>IT</given-names></name><name><surname>Kolonay</surname> <given-names>JF</given-names></name><name><surname>Brinkac</surname> <given-names>L</given-names></name><name><surname>Beanan</surname> <given-names>M</given-names></name><name><surname>Dodson</surname> <given-names>RJ</given-names></name><name><surname>Daugherty</surname> <given-names>SC</given-names></name><name><surname>Madupu</surname> <given-names>R</given-names></name><name><surname>Angiuoli</surname> <given-names>SV</given-names></name><name><surname>Durkin</surname> <given-names>AS</given-names></name><name><surname>Haft</surname> <given-names>DH</given-names></name><name><surname>Vamathevan</surname> <given-names>J</given-names></name><name><surname>Khouri</surname> <given-names>H</given-names></name><name><surname>Utterback</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Dimitrov</surname> <given-names>G</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Qin</surname> <given-names>H</given-names></name><name><surname>Weidman</surname> <given-names>J</given-names></name><name><surname>Tran</surname> <given-names>K</given-names></name><name><surname>Kang</surname> <given-names>K</given-names></name><name><surname>Hance</surname> <given-names>IR</given-names></name><name><surname>Nelson</surname> <given-names>KE</given-names></name><name><surname>Fraser</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant <italic>Staphylococcus aureus</italic> strain and a biofilm-producing methicillin-resistant <italic>Staphylococcus epidermidis</italic> strain</article-title><source>Journal of Bacteriology</source><volume>187</volume><fpage>2426</fpage><lpage>2438</lpage><pub-id pub-id-type="doi">10.1128/JB.187.7.2426-2438.2005</pub-id><pub-id pub-id-type="pmid">15774886</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gillaspy</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2006">2006</year><chapter-title>The <italic>Staphylococcus aureus</italic> NCTC8325 genome</chapter-title><person-group person-group-type="editor"><name><surname>Fischetti</surname> <given-names>V</given-names></name><name><surname>Novick</surname> <given-names>R</given-names></name><name><surname>Ferretti</surname> <given-names>J</given-names></name></person-group><source>Gram Positive Pathogens</source><publisher-name>ASM Press</publisher-name></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Miller</surname> <given-names>RR</given-names></name><name><surname>Farr</surname> <given-names>H</given-names></name><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Larner-Svensson</surname> <given-names>H</given-names></name><name><surname>Fung</surname> <given-names>R</given-names></name><name><surname>Godwin</surname> <given-names>H</given-names></name><name><surname>Knox</surname> <given-names>K</given-names></name><name><surname>Votintseva</surname> <given-names>A</given-names></name><name><surname>Everitt</surname> <given-names>RG</given-names></name><name><surname>Street</surname> <given-names>T</given-names></name><name><surname>Cule</surname> <given-names>M</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Harding</surname> <given-names>RM</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Within-host evolution of <italic>Staphylococcus aureus</italic> during asymptomatic carriage</article-title><source>PLoS One</source><volume>8</volume><elocation-id>e61319</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061319</pub-id><pub-id pub-id-type="pmid">23658690</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>NC</given-names></name><name><surname>Pichon</surname> <given-names>B</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Paul</surname> <given-names>J</given-names></name><name><surname>Blanc</surname> <given-names>DS</given-names></name><name><surname>Cole</surname> <given-names>K</given-names></name><name><surname>Collins</surname> <given-names>J</given-names></name><name><surname>Cortes</surname> <given-names>N</given-names></name><name><surname>Cubbon</surname> <given-names>M</given-names></name><name><surname>Gould</surname> <given-names>FK</given-names></name><name><surname>Jenks</surname> <given-names>PJ</given-names></name><name><surname>Llewelyn</surname> <given-names>M</given-names></name><name><surname>Nash</surname> <given-names>JQ</given-names></name><name><surname>Orendi</surname> <given-names>JM</given-names></name><name><surname>Paranthaman</surname> <given-names>K</given-names></name><name><surname>Price</surname> <given-names>JR</given-names></name><name><surname>Senn</surname> <given-names>L</given-names></name><name><surname>Thomas</surname> <given-names>HL</given-names></name><name><surname>Wyllie</surname> <given-names>S</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Peto</surname> <given-names>TEA</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Kearns</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Whole-genome sequencing reveals the contribution of long-term carriers in <italic>staphylococcus aureus</italic> outbreak investigation</article-title><source>Journal of Clinical Microbiology</source><volume>55</volume><fpage>2188</fpage><lpage>2197</lpage><pub-id pub-id-type="doi">10.1128/JCM.00363-17</pub-id><pub-id pub-id-type="pmid">28468851</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>NC</given-names></name><name><surname>Price</surname> <given-names>JR</given-names></name><name><surname>Cole</surname> <given-names>K</given-names></name><name><surname>Everitt</surname> <given-names>R</given-names></name><name><surname>Morgan</surname> <given-names>M</given-names></name><name><surname>Finney</surname> <given-names>J</given-names></name><name><surname>Kearns</surname> <given-names>AM</given-names></name><name><surname>Pichon</surname> <given-names>B</given-names></name><name><surname>Young</surname> <given-names>B</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Llewelyn</surname> <given-names>MJ</given-names></name><name><surname>Paul</surname> <given-names>J</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prediction of <italic>Staphylococcus aureus</italic> antimicrobial resistance by whole-genome sequencing</article-title><source>Journal of Clinical Microbiology</source><volume>52</volume><fpage>1182</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1128/JCM.03117-13</pub-id><pub-id pub-id-type="pmid">24501024</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guinane</surname> <given-names>CM</given-names></name><name><surname>Ben Zakour</surname> <given-names>NL</given-names></name><name><surname>Tormo-Mas</surname> <given-names>MA</given-names></name><name><surname>Weinert</surname> <given-names>LA</given-names></name><name><surname>Lowder</surname> <given-names>BV</given-names></name><name><surname>Cartwright</surname> <given-names>RA</given-names></name><name><surname>Smyth</surname> <given-names>DS</given-names></name><name><surname>Smyth</surname> <given-names>CJ</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name><name><surname>Gould</surname> <given-names>KA</given-names></name><name><surname>Witney</surname> <given-names>A</given-names></name><name><surname>Hinds</surname> <given-names>J</given-names></name><name><surname>Bollback</surname> <given-names>JP</given-names></name><name><surname>Rambaut</surname> <given-names>A</given-names></name><name><surname>Penadés</surname> <given-names>JR</given-names></name><name><surname>Fitzgerald</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evolutionary genomics of <italic>Staphylococcus aureus</italic> reveals insights into the origin and molecular basis of ruminant host adaptation</article-title><source>Genome Biology and Evolution</source><volume>2</volume><fpage>454</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1093/gbe/evq031</pub-id><pub-id pub-id-type="pmid">20624747</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gusfield</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Efficient algorithms for inferring evolutionary trees</article-title><source>Networks</source><volume>21</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1002/net.3230210104</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herron-Olson</surname> <given-names>L</given-names></name><name><surname>Fitzgerald</surname> <given-names>JR</given-names></name><name><surname>Musser</surname> <given-names>JM</given-names></name><name><surname>Kapur</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular correlates of host specialization in <italic>Staphylococcus aureus</italic></article-title><source>PLoS One</source><volume>2</volume><elocation-id>e1120</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001120</pub-id><pub-id pub-id-type="pmid">17971880</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>MT</given-names></name><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Day</surname> <given-names>NP</given-names></name><name><surname>Enright</surname> <given-names>MC</given-names></name><name><surname>Foster</surname> <given-names>TJ</given-names></name><name><surname>Moore</surname> <given-names>CE</given-names></name><name><surname>Hurst</surname> <given-names>L</given-names></name><name><surname>Atkin</surname> <given-names>R</given-names></name><name><surname>Barron</surname> <given-names>A</given-names></name><name><surname>Bason</surname> <given-names>N</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Chillingworth</surname> <given-names>C</given-names></name><name><surname>Chillingworth</surname> <given-names>T</given-names></name><name><surname>Churcher</surname> <given-names>C</given-names></name><name><surname>Clark</surname> <given-names>L</given-names></name><name><surname>Corton</surname> <given-names>C</given-names></name><name><surname>Cronin</surname> <given-names>A</given-names></name><name><surname>Doggett</surname> <given-names>J</given-names></name><name><surname>Dowd</surname> <given-names>L</given-names></name><name><surname>Feltwell</surname> <given-names>T</given-names></name><name><surname>Hance</surname> <given-names>Z</given-names></name><name><surname>Harris</surname> <given-names>B</given-names></name><name><surname>Hauser</surname> <given-names>H</given-names></name><name><surname>Holroyd</surname> <given-names>S</given-names></name><name><surname>Jagels</surname> <given-names>K</given-names></name><name><surname>James</surname> <given-names>KD</given-names></name><name><surname>Lennard</surname> <given-names>N</given-names></name><name><surname>Line</surname> <given-names>A</given-names></name><name><surname>Mayes</surname> <given-names>R</given-names></name><name><surname>Moule</surname> <given-names>S</given-names></name><name><surname>Mungall</surname> <given-names>K</given-names></name><name><surname>Ormond</surname> <given-names>D</given-names></name><name><surname>Quail</surname> <given-names>MA</given-names></name><name><surname>Rabbinowitsch</surname> <given-names>E</given-names></name><name><surname>Rutherford</surname> <given-names>K</given-names></name><name><surname>Sanders</surname> <given-names>M</given-names></name><name><surname>Sharp</surname> <given-names>S</given-names></name><name><surname>Simmonds</surname> <given-names>M</given-names></name><name><surname>Stevens</surname> <given-names>K</given-names></name><name><surname>Whitehead</surname> <given-names>S</given-names></name><name><surname>Barrell</surname> <given-names>BG</given-names></name><name><surname>Spratt</surname> <given-names>BG</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Complete genomes of two clinical <italic>Staphylococcus aureus</italic> strains: evidence for the rapid evolution of virulence and drug resistance</article-title><source>PNAS</source><volume>101</volume><fpage>9786</fpage><lpage>9791</lpage><pub-id pub-id-type="doi">10.1073/pnas.0402521101</pub-id><pub-id pub-id-type="pmid">15213324</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>MT</given-names></name><name><surname>Hsu</surname> <given-names>LY</given-names></name><name><surname>Kurt</surname> <given-names>K</given-names></name><name><surname>Weinert</surname> <given-names>LA</given-names></name><name><surname>Mather</surname> <given-names>AE</given-names></name><name><surname>Harris</surname> <given-names>SR</given-names></name><name><surname>Strommenger</surname> <given-names>B</given-names></name><name><surname>Layer</surname> <given-names>F</given-names></name><name><surname>Witte</surname> <given-names>W</given-names></name><name><surname>de Lencastre</surname> <given-names>H</given-names></name><name><surname>Skov</surname> <given-names>R</given-names></name><name><surname>Westh</surname> <given-names>H</given-names></name><name><surname>Zemlicková</surname> <given-names>H</given-names></name><name><surname>Coombs</surname> <given-names>G</given-names></name><name><surname>Kearns</surname> <given-names>AM</given-names></name><name><surname>Hill</surname> <given-names>RL</given-names></name><name><surname>Edgeworth</surname> <given-names>J</given-names></name><name><surname>Gould</surname> <given-names>I</given-names></name><name><surname>Gant</surname> <given-names>V</given-names></name><name><surname>Cooke</surname> <given-names>J</given-names></name><name><surname>Edwards</surname> <given-names>GF</given-names></name><name><surname>McAdam</surname> <given-names>PR</given-names></name><name><surname>Templeton</surname> <given-names>KE</given-names></name><name><surname>McCann</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Castillo-Ramírez</surname> <given-names>S</given-names></name><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Hudson</surname> <given-names>LO</given-names></name><name><surname>Enright</surname> <given-names>MC</given-names></name><name><surname>Balloux</surname> <given-names>F</given-names></name><name><surname>Aanensen</surname> <given-names>DM</given-names></name><name><surname>Spratt</surname> <given-names>BG</given-names></name><name><surname>Fitzgerald</surname> <given-names>JR</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Achtman</surname> <given-names>M</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Nübel</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant <italic>Staphylococcus aureus</italic> pandemic</article-title><source>Genome Research</source><volume>23</volume><fpage>653</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1101/gr.147710.112</pub-id><pub-id pub-id-type="pmid">23299977</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>MT</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name><name><surname>Corton</surname> <given-names>C</given-names></name><name><surname>Quail</surname> <given-names>MA</given-names></name><name><surname>Cockfield</surname> <given-names>JD</given-names></name><name><surname>Pathak</surname> <given-names>S</given-names></name><name><surname>Batra</surname> <given-names>R</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Edgeworth</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genome sequence of a recently emerged, highly transmissible, multi-antibiotic- and antiseptic-resistant variant of methicillin-resistant <italic>Staphylococcus aureus</italic>, sequence type 239 (TW)</article-title><source>Journal of Bacteriology</source><volume>192</volume><fpage>888</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1128/JB.01255-09</pub-id><pub-id pub-id-type="pmid">19948800</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howden</surname> <given-names>BP</given-names></name><name><surname>McEvoy</surname> <given-names>CR</given-names></name><name><surname>Allen</surname> <given-names>DL</given-names></name><name><surname>Chua</surname> <given-names>K</given-names></name><name><surname>Gao</surname> <given-names>W</given-names></name><name><surname>Harrison</surname> <given-names>PF</given-names></name><name><surname>Bell</surname> <given-names>J</given-names></name><name><surname>Coombs</surname> <given-names>G</given-names></name><name><surname>Bennett-Wood</surname> <given-names>V</given-names></name><name><surname>Porter</surname> <given-names>JL</given-names></name><name><surname>Robins-Browne</surname> <given-names>R</given-names></name><name><surname>Davies</surname> <given-names>JK</given-names></name><name><surname>Seemann</surname> <given-names>T</given-names></name><name><surname>Stinear</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Evolution of multidrug resistance during <italic>Staphylococcus aureus</italic> infection involves mutation of the essential two component regulator WalKR</article-title><source>PLoS Pathogens</source><volume>7</volume><elocation-id>e1002359</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002359</pub-id><pub-id pub-id-type="pmid">22102812</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howden</surname> <given-names>BP</given-names></name><name><surname>Smith</surname> <given-names>DJ</given-names></name><name><surname>Mansell</surname> <given-names>A</given-names></name><name><surname>Johnson</surname> <given-names>PD</given-names></name><name><surname>Ward</surname> <given-names>PB</given-names></name><name><surname>Stinear</surname> <given-names>TP</given-names></name><name><surname>Davies</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant <italic>Staphylococcus aureus</italic> bacteraemia</article-title><source>BMC Microbiology</source><volume>8</volume><elocation-id>39</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-8-39</pub-id><pub-id pub-id-type="pmid">18304359</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname> <given-names>Z</given-names></name><name><surname>Caccamo</surname> <given-names>M</given-names></name><name><surname>Turner</surname> <given-names>I</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>De novo assembly and genotyping of variants using colored de Bruijn graphs</article-title><source>Nature Genetics</source><volume>44</volume><fpage>226</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1038/ng.1028</pub-id><pub-id pub-id-type="pmid">22231483</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname> <given-names>M</given-names></name><name><surname>Sato</surname> <given-names>Y</given-names></name><name><surname>Kawashima</surname> <given-names>M</given-names></name><name><surname>Furumichi</surname> <given-names>M</given-names></name><name><surname>Tanabe</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>KEGG as a reference resource for gene and protein annotation</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D457</fpage><lpage>D462</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1070</pub-id><pub-id pub-id-type="pmid">26476454</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kluytmans</surname> <given-names>J</given-names></name><name><surname>van Belkum</surname> <given-names>A</given-names></name><name><surname>Verbrugh</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Nasal carriage of <italic>Staphylococcus aureus</italic>: epidemiology, underlying mechanisms, and associated risks</article-title><source>Clinical Microbiology Reviews</source><volume>10</volume><fpage>505</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">9227864</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname> <given-names>M</given-names></name><name><surname>Ohta</surname> <given-names>T</given-names></name><name><surname>Uchiyama</surname> <given-names>I</given-names></name><name><surname>Baba</surname> <given-names>T</given-names></name><name><surname>Yuzawa</surname> <given-names>H</given-names></name><name><surname>Kobayashi</surname> <given-names>I</given-names></name><name><surname>Cui</surname> <given-names>L</given-names></name><name><surname>Oguchi</surname> <given-names>A</given-names></name><name><surname>Aoki</surname> <given-names>K</given-names></name><name><surname>Nagai</surname> <given-names>Y</given-names></name><name><surname>Lian</surname> <given-names>J</given-names></name><name><surname>Ito</surname> <given-names>T</given-names></name><name><surname>Kanamori</surname> <given-names>M</given-names></name><name><surname>Matsumaru</surname> <given-names>H</given-names></name><name><surname>Maruyama</surname> <given-names>A</given-names></name><name><surname>Murakami</surname> <given-names>H</given-names></name><name><surname>Hosoyama</surname> <given-names>A</given-names></name><name><surname>Mizutani-Ui</surname> <given-names>Y</given-names></name><name><surname>Takahashi</surname> <given-names>NK</given-names></name><name><surname>Sawano</surname> <given-names>T</given-names></name><name><surname>Inoue</surname> <given-names>R</given-names></name><name><surname>Kaito</surname> <given-names>C</given-names></name><name><surname>Sekimizu</surname> <given-names>K</given-names></name><name><surname>Hirakawa</surname> <given-names>H</given-names></name><name><surname>Kuhara</surname> <given-names>S</given-names></name><name><surname>Goto</surname> <given-names>S</given-names></name><name><surname>Yabuzaki</surname> <given-names>J</given-names></name><name><surname>Kanehisa</surname> <given-names>M</given-names></name><name><surname>Yamashita</surname> <given-names>A</given-names></name><name><surname>Oshima</surname> <given-names>K</given-names></name><name><surname>Furuya</surname> <given-names>K</given-names></name><name><surname>Yoshino</surname> <given-names>C</given-names></name><name><surname>Shiba</surname> <given-names>T</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Ogasawara</surname> <given-names>N</given-names></name><name><surname>Hayashi</surname> <given-names>H</given-names></name><name><surname>Hiramatsu</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Whole genome sequencing of meticillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>The Lancet</source><volume>357</volume><fpage>1225</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)04403-2</pub-id><pub-id pub-id-type="pmid">11418146</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laabei</surname> <given-names>M</given-names></name><name><surname>Recker</surname> <given-names>M</given-names></name><name><surname>Rudkin</surname> <given-names>JK</given-names></name><name><surname>Aldeljawi</surname> <given-names>M</given-names></name><name><surname>Gulay</surname> <given-names>Z</given-names></name><name><surname>Sloan</surname> <given-names>TJ</given-names></name><name><surname>Williams</surname> <given-names>P</given-names></name><name><surname>Endres</surname> <given-names>JL</given-names></name><name><surname>Bayles</surname> <given-names>KW</given-names></name><name><surname>Fey</surname> <given-names>PD</given-names></name><name><surname>Yajjala</surname> <given-names>VK</given-names></name><name><surname>Widhelm</surname> <given-names>T</given-names></name><name><surname>Hawkins</surname> <given-names>E</given-names></name><name><surname>Lewis</surname> <given-names>K</given-names></name><name><surname>Parfett</surname> <given-names>S</given-names></name><name><surname>Scowen</surname> <given-names>L</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Holden</surname> <given-names>M</given-names></name><name><surname>Wilson</surname> <given-names>D</given-names></name><name><surname>Read</surname> <given-names>TD</given-names></name><name><surname>van den Elsen</surname> <given-names>J</given-names></name><name><surname>Priest</surname> <given-names>NK</given-names></name><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Hurst</surname> <given-names>LD</given-names></name><name><surname>Josefsson</surname> <given-names>E</given-names></name><name><surname>Massey</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Predicting the virulence of MRSA from its genome sequence</article-title><source>Genome Research</source><volume>24</volume><fpage>839</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1101/gr.165415.113</pub-id><pub-id pub-id-type="pmid">24717264</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laabei</surname> <given-names>M</given-names></name><name><surname>Uhlemann</surname> <given-names>AC</given-names></name><name><surname>Lowy</surname> <given-names>FD</given-names></name><name><surname>Austin</surname> <given-names>ED</given-names></name><name><surname>Yokoyama</surname> <given-names>M</given-names></name><name><surname>Ouadi</surname> <given-names>K</given-names></name><name><surname>Feil</surname> <given-names>E</given-names></name><name><surname>Thorpe</surname> <given-names>HA</given-names></name><name><surname>Williams</surname> <given-names>B</given-names></name><name><surname>Perkins</surname> <given-names>M</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Clarke</surname> <given-names>SR</given-names></name><name><surname>Dordel</surname> <given-names>J</given-names></name><name><surname>Holden</surname> <given-names>M</given-names></name><name><surname>Votintseva</surname> <given-names>AA</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Recker</surname> <given-names>M</given-names></name><name><surname>Massey</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Evolutionary trade-offs underlie the multi-faceted virulence of <italic>staphylococcus aureus</italic></article-title><source>PLoS Biology</source><volume>13</volume><elocation-id>e1002229</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002229</pub-id><pub-id pub-id-type="pmid">26331877</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane-Khadka</surname> <given-names>R</given-names></name><name><surname>Riordan</surname> <given-names>JT</given-names></name><name><surname>Delgado</surname> <given-names>A</given-names></name><name><surname>Muthaiyan</surname> <given-names>A</given-names></name><name><surname>Reynolds</surname> <given-names>TD</given-names></name><name><surname>Wilkinson</surname> <given-names>BJ</given-names></name><name><surname>Gustafson</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism of <italic>Staphylococcus aureus</italic></article-title><source>Journal of Applied Microbiology</source><volume>105</volume><fpage>1973</fpage><lpage>1981</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2008.03956.x</pub-id><pub-id pub-id-type="pmid">19120644</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname> <given-names>JA</given-names></name><name><surname>Kremer</surname> <given-names>PH</given-names></name><name><surname>Manso</surname> <given-names>AS</given-names></name><name><surname>Croucher</surname> <given-names>NJ</given-names></name><name><surname>Ferwerda</surname> <given-names>B</given-names></name><name><surname>Serón</surname> <given-names>MV</given-names></name><name><surname>Oggioni</surname> <given-names>MR</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Brouwer</surname> <given-names>MC</given-names></name><name><surname>van der Ende</surname> <given-names>A</given-names></name><name><surname>van de Beek</surname> <given-names>D</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis</article-title><source>Microbial Genomics</source><volume>3</volume><fpage>e000103</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000103</pub-id><pub-id pub-id-type="pmid">28348877</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname> <given-names>MG</given-names></name><name><surname>Cue</surname> <given-names>D</given-names></name><name><surname>Roux</surname> <given-names>CM</given-names></name><name><surname>Dunman</surname> <given-names>PM</given-names></name><name><surname>Lee</surname> <given-names>CY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rsp inhibits attachment and biofilm formation by repressing fnbA in <italic>Staphylococcus aureus</italic> MW2</article-title><source>Journal of Bacteriology</source><volume>193</volume><fpage>5231</fpage><lpage>5241</lpage><pub-id pub-id-type="doi">10.1128/JB.05454-11</pub-id><pub-id pub-id-type="pmid">21804010</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname> <given-names>TD</given-names></name><name><surname>Flett</surname> <given-names>KB</given-names></name><name><surname>Yelin</surname> <given-names>I</given-names></name><name><surname>Martin</surname> <given-names>TR</given-names></name><name><surname>McAdam</surname> <given-names>AJ</given-names></name><name><surname>Priebe</surname> <given-names>GP</given-names></name><name><surname>Kishony</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures</article-title><source>Nature Genetics</source><volume>46</volume><fpage>82</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1038/ng.2848</pub-id><pub-id pub-id-type="pmid">24316980</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname> <given-names>TD</given-names></name><name><surname>Michel</surname> <given-names>JB</given-names></name><name><surname>Aingaran</surname> <given-names>M</given-names></name><name><surname>Potter-Bynoe</surname> <given-names>G</given-names></name><name><surname>Roux</surname> <given-names>D</given-names></name><name><surname>Davis</surname> <given-names>MR</given-names></name><name><surname>Skurnik</surname> <given-names>D</given-names></name><name><surname>Leiby</surname> <given-names>N</given-names></name><name><surname>LiPuma</surname> <given-names>JJ</given-names></name><name><surname>Goldberg</surname> <given-names>JB</given-names></name><name><surname>McAdam</surname> <given-names>AJ</given-names></name><name><surname>Priebe</surname> <given-names>GP</given-names></name><name><surname>Kishony</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes</article-title><source>Nature Genetics</source><volume>43</volume><fpage>1275</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1038/ng.997</pub-id><pub-id pub-id-type="pmid">22081229</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan-Klumpler</surname> <given-names>FJ</given-names></name><name><surname>De Silva</surname> <given-names>N</given-names></name><name><surname>Boehme</surname> <given-names>U</given-names></name><name><surname>Rogers</surname> <given-names>MB</given-names></name><name><surname>Velarde</surname> <given-names>G</given-names></name><name><surname>McQuillan</surname> <given-names>JA</given-names></name><name><surname>Carver</surname> <given-names>T</given-names></name><name><surname>Aslett</surname> <given-names>M</given-names></name><name><surname>Olsen</surname> <given-names>C</given-names></name><name><surname>Subramanian</surname> <given-names>S</given-names></name><name><surname>Phan</surname> <given-names>I</given-names></name><name><surname>Farris</surname> <given-names>C</given-names></name><name><surname>Mitra</surname> <given-names>S</given-names></name><name><surname>Ramasamy</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Tivey</surname> <given-names>A</given-names></name><name><surname>Jackson</surname> <given-names>A</given-names></name><name><surname>Houston</surname> <given-names>R</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Holden</surname> <given-names>M</given-names></name><name><surname>Harb</surname> <given-names>OS</given-names></name><name><surname>Brunk</surname> <given-names>BP</given-names></name><name><surname>Myler</surname> <given-names>PJ</given-names></name><name><surname>Roos</surname> <given-names>D</given-names></name><name><surname>Carrington</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>DF</given-names></name><name><surname>Hertz-Fowler</surname> <given-names>C</given-names></name><name><surname>Berriman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>GeneDB--an annotation database for pathogens</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>D98</fpage><lpage>D108</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr1032</pub-id><pub-id pub-id-type="pmid">22116062</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowder</surname> <given-names>BV</given-names></name><name><surname>Guinane</surname> <given-names>CM</given-names></name><name><surname>Ben Zakour</surname> <given-names>NL</given-names></name><name><surname>Weinert</surname> <given-names>LA</given-names></name><name><surname>Conway-Morris</surname> <given-names>A</given-names></name><name><surname>Cartwright</surname> <given-names>RA</given-names></name><name><surname>Simpson</surname> <given-names>AJ</given-names></name><name><surname>Rambaut</surname> <given-names>A</given-names></name><name><surname>Nübel</surname> <given-names>U</given-names></name><name><surname>Fitzgerald</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Recent human-to-poultry host jump, adaptation, and pandemic spread of <italic>Staphylococcus aureus</italic></article-title><source>PNAS</source><volume>106</volume><fpage>19545</fpage><lpage>19550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909285106</pub-id><pub-id pub-id-type="pmid">19884497</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löytynoja</surname> <given-names>A</given-names></name><name><surname>Vilella</surname> <given-names>AJ</given-names></name><name><surname>Goldman</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Accurate extension of multiple sequence alignments using a phylogeny-aware graph algorithm</article-title><source>Bioinformatics</source><volume>28</volume><fpage>1684</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts198</pub-id><pub-id pub-id-type="pmid">22531217</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunter</surname> <given-names>G</given-names></name><name><surname>Goodson</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads</article-title><source>Genome Research</source><volume>21</volume><fpage>936</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1101/gr.111120.110</pub-id><pub-id pub-id-type="pmid">20980556</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Łeski</surname> <given-names>TA</given-names></name><name><surname>Tomasz</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of <italic>Staphylococcus aureus</italic>: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A</article-title><source>Journal of Bacteriology</source><volume>187</volume><fpage>1815</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.1128/JB.187.5.1815-1824.2005</pub-id><pub-id pub-id-type="pmid">15716453</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname> <given-names>E</given-names></name><name><surname>Levin</surname> <given-names>BR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Within-host evolution for the invasiveness of commensal bacteria: an experimental study of bacteremias resulting from <italic>Haemophilus influenzae</italic> nasal carriage</article-title><source>The Journal of Infectious Diseases</source><volume>196</volume><fpage>1068</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1086/520934</pub-id><pub-id pub-id-type="pmid">17763330</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markussen</surname> <given-names>T</given-names></name><name><surname>Marvig</surname> <given-names>RL</given-names></name><name><surname>Gómez-Lozano</surname> <given-names>M</given-names></name><name><surname>Aanæs</surname> <given-names>K</given-names></name><name><surname>Burleigh</surname> <given-names>AE</given-names></name><name><surname>Høiby</surname> <given-names>N</given-names></name><name><surname>Johansen</surname> <given-names>HK</given-names></name><name><surname>Molin</surname> <given-names>S</given-names></name><name><surname>Jelsbak</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Environmental heterogeneity drives within-host diversification and evolution of <italic>Pseudomonas aeruginosa</italic></article-title><source>mBio</source><volume>5</volume><elocation-id>e01592-14</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01592-14</pub-id><pub-id pub-id-type="pmid">25227464</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marvig</surname> <given-names>RL</given-names></name><name><surname>Johansen</surname> <given-names>HK</given-names></name><name><surname>Molin</surname> <given-names>S</given-names></name><name><surname>Jelsbak</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome analysis of a transmissible lineage of <italic>pseudomonas aeruginosa</italic> reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators</article-title><source>PLoS Genetics</source><volume>9</volume><elocation-id>e1003741</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003741</pub-id><pub-id pub-id-type="pmid">24039595</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marvig</surname> <given-names>RL</given-names></name><name><surname>Sommer</surname> <given-names>LM</given-names></name><name><surname>Molin</surname> <given-names>S</given-names></name><name><surname>Johansen</surname> <given-names>HK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Convergent evolution and adaptation of <italic>Pseudomonas aeruginosa</italic> within patients with cystic fibrosis</article-title><source>Nature Genetics</source><volume>47</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/ng.3148</pub-id><pub-id pub-id-type="pmid">25401299</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname> <given-names>JH</given-names></name><name><surname>Kreitman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Adaptive protein evolution at the Adh locus in Drosophila</article-title><source>Nature</source><volume>351</volume><fpage>652</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1038/351652a0</pub-id><pub-id pub-id-type="pmid">1904993</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Méthot</surname> <given-names>PO</given-names></name><name><surname>Alizon</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>What is a pathogen? toward a process view of host-parasite interactions</article-title><source>Virulence</source><volume>5</volume><fpage>775</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.4161/21505594.2014.960726</pub-id><pub-id pub-id-type="pmid">25483864</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moeller</surname> <given-names>AH</given-names></name><name><surname>Caro-Quintero</surname> <given-names>A</given-names></name><name><surname>Mjungu</surname> <given-names>D</given-names></name><name><surname>Georgiev</surname> <given-names>AV</given-names></name><name><surname>Lonsdorf</surname> <given-names>EV</given-names></name><name><surname>Muller</surname> <given-names>MN</given-names></name><name><surname>Pusey</surname> <given-names>AE</given-names></name><name><surname>Peeters</surname> <given-names>M</given-names></name><name><surname>Hahn</surname> <given-names>BH</given-names></name><name><surname>Ochman</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cospeciation of gut microbiota with hominids</article-title><source>Science</source><volume>353</volume><fpage>380</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1126/science.aaf3951</pub-id><pub-id pub-id-type="pmid">27463672</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moxon</surname> <given-names>ER</given-names></name><name><surname>Murphy</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title><italic>Haemophilus influenzae</italic> bacteremia and meningitis resulting from survival of a single organism</article-title><source>PNAS</source><volume>75</volume><fpage>1534</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1073/pnas.75.3.1534</pub-id><pub-id pub-id-type="pmid">306628</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname> <given-names>V</given-names></name><name><surname>Elasri</surname> <given-names>MO</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SAMMD: <italic>Staphylococcus aureus</italic> microarray meta-database</article-title><source>BMC Genomics</source><volume>8</volume><elocation-id>351</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-8-351</pub-id><pub-id pub-id-type="pmid">17910768</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname> <given-names>RP</given-names></name><name><surname>Geisinger</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Quorum sensing in staphylococci</article-title><source>Annual Review of Genetics</source><volume>42</volume><fpage>541</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1146/annurev.genet.42.110807.091640</pub-id><pub-id pub-id-type="pmid">18713030</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname> <given-names>KL</given-names></name><name><surname>Krishna</surname> <given-names>A</given-names></name><name><surname>Wigneshweraraj</surname> <given-names>S</given-names></name><name><surname>Edwards</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>What role does the quorum-sensing accessory gene regulator system play during <italic>Staphylococcus aureus</italic> bacteremia?</article-title><source>Trends in Microbiology</source><volume>22</volume><fpage>676</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2014.09.002</pub-id><pub-id pub-id-type="pmid">25300477</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietiäinen</surname> <given-names>M</given-names></name><name><surname>François</surname> <given-names>P</given-names></name><name><surname>Hyyryläinen</surname> <given-names>HL</given-names></name><name><surname>Tangomo</surname> <given-names>M</given-names></name><name><surname>Sass</surname> <given-names>V</given-names></name><name><surname>Sahl</surname> <given-names>HG</given-names></name><name><surname>Schrenzel</surname> <given-names>J</given-names></name><name><surname>Kontinen</surname> <given-names>VP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transcriptome analysis of the responses of <italic>Staphylococcus aureus</italic> to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance</article-title><source>BMC Genomics</source><volume>10</volume><elocation-id>429</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-10-429</pub-id><pub-id pub-id-type="pmid">19751498</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollitt</surname> <given-names>EJ</given-names></name><name><surname>West</surname> <given-names>SA</given-names></name><name><surname>Crusz</surname> <given-names>SA</given-names></name><name><surname>Burton-Chellew</surname> <given-names>MN</given-names></name><name><surname>Diggle</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cooperation, quorum sensing, and evolution of virulence in S<italic>taphylococcus aureus</italic></article-title><source>Infection and Immunity</source><volume>82</volume><fpage>1045</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1128/IAI.01216-13</pub-id><pub-id pub-id-type="pmid">24343650</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prajsnar</surname> <given-names>TK</given-names></name><name><surname>Hamilton</surname> <given-names>R</given-names></name><name><surname>Garcia-Lara</surname> <given-names>J</given-names></name><name><surname>McVicker</surname> <given-names>G</given-names></name><name><surname>Williams</surname> <given-names>A</given-names></name><name><surname>Boots</surname> <given-names>M</given-names></name><name><surname>Foster</surname> <given-names>SJ</given-names></name><name><surname>Renshaw</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A privileged intraphagocyte niche is responsible for disseminated infection of <italic>Staphylococcus aureus</italic> in a zebrafish model</article-title><source>Cellular Microbiology</source><volume>14</volume><fpage>1600</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2012.01826.x</pub-id><pub-id pub-id-type="pmid">22694745</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pupko</surname> <given-names>T</given-names></name><name><surname>Pe'er</surname> <given-names>I</given-names></name><name><surname>Shamir</surname> <given-names>R</given-names></name><name><surname>Graur</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A fast algorithm for joint reconstruction of ancestral amino acid sequences</article-title><source>Molecular Biology and Evolution</source><volume>17</volume><fpage>890</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a026369</pub-id><pub-id pub-id-type="pmid">10833195</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Core Team</collab></person-group><year iso-8601-date="2015">2015</year><source>R: A Language and Environment for Statistical Computing</source><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rand</surname> <given-names>DM</given-names></name><name><surname>Kann</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Excess amino acid polymorphism in mitochondrial DNA: contrasts among genes from Drosophila, mice, and humans</article-title><source>Molecular Biology and Evolution</source><volume>13</volume><fpage>735</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a025634</pub-id><pub-id pub-id-type="pmid">8754210</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname> <given-names>DJ</given-names></name><name><surname>Bargum</surname> <given-names>K</given-names></name><name><surname>Kokko</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The tragedy of the commons in evolutionary biology</article-title><source>Trends in Ecology &amp; Evolution</source><volume>22</volume><fpage>643</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1016/j.tree.2007.07.009</pub-id><pub-id pub-id-type="pmid">17981363</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>DA</given-names></name><name><surname>Monk</surname> <given-names>AB</given-names></name><name><surname>Cooper</surname> <given-names>JE</given-names></name><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Enright</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Evolutionary genetics of the accessory gene regulator (agr) locus in <italic>Staphylococcus aureus</italic></article-title><source>Journal of Bacteriology</source><volume>187</volume><fpage>8312</fpage><lpage>8321</lpage><pub-id pub-id-type="doi">10.1128/JB.187.24.8312-8321.2005</pub-id><pub-id pub-id-type="pmid">16321935</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roeder</surname> <given-names>K</given-names></name><name><surname>Wasserman</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-wide significance levels and weighted hypothesis testing</article-title><source>Statistical Science</source><volume>24</volume><fpage>398</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1214/09-STS289</pub-id><pub-id pub-id-type="pmid">20711421</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitou</surname> <given-names>N</given-names></name><name><surname>Nei</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>The neighbor-joining method: a new method for reconstructing phylogenetic trees</article-title><source>Molecular Biology and Evolution</source><volume>4</volume><fpage>406</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">3447015</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakoulas</surname> <given-names>G</given-names></name><name><surname>Moise</surname> <given-names>PA</given-names></name><name><surname>Rybak</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Accessory gene regulator dysfunction: an advantage for <italic>Staphylococcus aureus</italic> in health-care settings?</article-title><source>The Journal of Infectious Diseases</source><volume>199</volume><fpage>1558</fpage><lpage>1559</lpage><pub-id pub-id-type="doi">10.1086/598607</pub-id><pub-id pub-id-type="pmid">19392634</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname> <given-names>SA</given-names></name><name><surname>Hartl</surname> <given-names>DL</given-names></name><name><surname>Sawyer, DL Hartl</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Population genetics of polymorphism and divergence</article-title><source>Genetics</source><volume>132</volume><fpage>1161</fpage><lpage>1176</lpage><pub-id pub-id-type="pmid">1459433</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schijffelen</surname> <given-names>MJ</given-names></name><name><surname>Boel</surname> <given-names>CH</given-names></name><name><surname>van Strijp</surname> <given-names>JA</given-names></name><name><surname>Fluit</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Whole genome analysis of a livestock-associated methicillin-resistant <italic>Staphylococcus aureus</italic> ST398 isolate from a case of human endocarditis</article-title><source>BMC Genomics</source><volume>11</volume><elocation-id>376</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-11-376</pub-id><pub-id pub-id-type="pmid">20546576</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname> <given-names>SK</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Meric</surname> <given-names>G</given-names></name><name><surname>Torralbo</surname> <given-names>A</given-names></name><name><surname>Jolley</surname> <given-names>KA</given-names></name><name><surname>Kelly</surname> <given-names>DJ</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Maiden</surname> <given-names>MC</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Falush</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide association study identifies vitamin B5 biosynthesis as a host specificity factor in Campylobacter</article-title><source>PNAS</source><volume>110</volume><fpage>11923</fpage><lpage>11927</lpage><pub-id pub-id-type="doi">10.1073/pnas.1305559110</pub-id><pub-id pub-id-type="pmid">23818615</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shopsin</surname> <given-names>B</given-names></name><name><surname>Eaton</surname> <given-names>C</given-names></name><name><surname>Wasserman</surname> <given-names>GA</given-names></name><name><surname>Mathema</surname> <given-names>B</given-names></name><name><surname>Adhikari</surname> <given-names>RP</given-names></name><name><surname>Agolory</surname> <given-names>S</given-names></name><name><surname>Altman</surname> <given-names>DR</given-names></name><name><surname>Holzman</surname> <given-names>RS</given-names></name><name><surname>Kreiswirth</surname> <given-names>BN</given-names></name><name><surname>Novick</surname> <given-names>RP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mutations in agr do not persist in natural populations of methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>The Journal of Infectious Diseases</source><volume>202</volume><fpage>1593</fpage><lpage>1599</lpage><pub-id pub-id-type="doi">10.1086/656915</pub-id><pub-id pub-id-type="pmid">20942648</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname> <given-names>DS</given-names></name><name><surname>Kafer</surname> <given-names>JM</given-names></name><name><surname>Wasserman</surname> <given-names>GA</given-names></name><name><surname>Velickovic</surname> <given-names>L</given-names></name><name><surname>Mathema</surname> <given-names>B</given-names></name><name><surname>Holzman</surname> <given-names>RS</given-names></name><name><surname>Knipe</surname> <given-names>TA</given-names></name><name><surname>Becker</surname> <given-names>K</given-names></name><name><surname>von Eiff</surname> <given-names>C</given-names></name><name><surname>Peters</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Kreiswirth</surname> <given-names>BN</given-names></name><name><surname>Novick</surname> <given-names>RP</given-names></name><name><surname>Shopsin</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nasal carriage as a source of <italic>agr</italic>-defective <italic>Staphylococcus aureus</italic> bacteremia</article-title><source>The Journal of Infectious Diseases</source><volume>206</volume><fpage>1168</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis483</pub-id><pub-id pub-id-type="pmid">22859823</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokurenko</surname> <given-names>EV</given-names></name><name><surname>Gomulkiewicz</surname> <given-names>R</given-names></name><name><surname>Dykhuizen</surname> <given-names>DE</given-names></name><name><surname>Gomulkiewicz, DE Dykhuizen</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Source-sink dynamics of virulence evolution</article-title><source>Nature Reviews Microbiology</source><volume>4</volume><fpage>548</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1446</pub-id><pub-id pub-id-type="pmid">16778839</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamatakis</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies</article-title><source>Bioinformatics</source><volume>30</volume><fpage>1312</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu033</pub-id><pub-id pub-id-type="pmid">24451623</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stapels</surname> <given-names>DA</given-names></name><name><surname>Ramyar</surname> <given-names>KX</given-names></name><name><surname>Bischoff</surname> <given-names>M</given-names></name><name><surname>von Köckritz-Blickwede</surname> <given-names>M</given-names></name><name><surname>Milder</surname> <given-names>FJ</given-names></name><name><surname>Ruyken</surname> <given-names>M</given-names></name><name><surname>Eisenbeis</surname> <given-names>J</given-names></name><name><surname>McWhorter</surname> <given-names>WJ</given-names></name><name><surname>Herrmann</surname> <given-names>M</given-names></name><name><surname>van Kessel</surname> <given-names>KP</given-names></name><name><surname>Geisbrecht</surname> <given-names>BV</given-names></name><name><surname>Rooijakkers</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Staphylococcus aureus</italic> secretes a unique class of neutrophil serine protease inhibitors</article-title><source>PNAS</source><volume>111</volume><fpage>13187</fpage><lpage>13192</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407616111</pub-id><pub-id pub-id-type="pmid">25161283</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traber</surname> <given-names>KE</given-names></name><name><surname>Lee</surname> <given-names>E</given-names></name><name><surname>Benson</surname> <given-names>S</given-names></name><name><surname>Corrigan</surname> <given-names>R</given-names></name><name><surname>Cantera</surname> <given-names>M</given-names></name><name><surname>Shopsin</surname> <given-names>B</given-names></name><name><surname>Novick</surname> <given-names>RP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>agr function in clinical <italic>Staphylococcus aureus</italic> isolates</article-title><source>Microbiology</source><volume>154</volume><fpage>2265</fpage><lpage>2274</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2007/011874-0</pub-id><pub-id pub-id-type="pmid">18667559</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname> <given-names>PJ</given-names></name><name><surname>Ley</surname> <given-names>RE</given-names></name><name><surname>Hamady</surname> <given-names>M</given-names></name><name><surname>Fraser-Liggett</surname> <given-names>CM</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The human microbiome project</article-title><source>Nature</source><volume>449</volume><fpage>804</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1038/nature06244</pub-id><pub-id pub-id-type="pmid">17943116</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Eiff</surname> <given-names>C</given-names></name><name><surname>Becker</surname> <given-names>K</given-names></name><name><surname>Machka</surname> <given-names>K</given-names></name><name><surname>Stammer</surname> <given-names>H</given-names></name><name><surname>Peters</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nasal carriage as a source of <italic>Staphylococcus aureus</italic> bacteremia. Study Group</article-title><source>New England Journal of Medicine</source><volume>344</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1056/NEJM200101043440102</pub-id><pub-id pub-id-type="pmid">11136954</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Hernandez</surname> <given-names>RD</given-names></name><name><surname>Andolfatto</surname> <given-names>P</given-names></name><name><surname>Przeworski</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A population genetics-phylogenetics approach to inferring natural selection in coding sequences</article-title><source>PLoS Genetics</source><volume>7</volume><elocation-id>e1002395</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002395</pub-id><pub-id pub-id-type="pmid">22144911</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Estimating diversifying selection and functional constraint in the presence of recombination</article-title><source>Genetics</source><volume>172</volume><fpage>1411</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1534/genetics.105.044917</pub-id><pub-id pub-id-type="pmid">16387887</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>ES</given-names></name><name><surname>Tan</surname> <given-names>J</given-names></name><name><surname>Eells</surname> <given-names>S</given-names></name><name><surname>Rieg</surname> <given-names>G</given-names></name><name><surname>Tagudar</surname> <given-names>G</given-names></name><name><surname>Miller</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Body site colonization in patients with community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> and other types of S. aureus skin infections</article-title><source>Clinical Microbiology and Infection</source><volume>16</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02836.x</pub-id><pub-id pub-id-type="pmid">19689469</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Fung</surname> <given-names>R</given-names></name><name><surname>Larner-Svensson</surname> <given-names>H</given-names></name><name><surname>Votintseva</surname> <given-names>AA</given-names></name><name><surname>Miller</surname> <given-names>RR</given-names></name><name><surname>Godwin</surname> <given-names>H</given-names></name><name><surname>Knox</surname> <given-names>K</given-names></name><name><surname>Everitt</surname> <given-names>RG</given-names></name><name><surname>Iqbal</surname> <given-names>Z</given-names></name><name><surname>Rimmer</surname> <given-names>AJ</given-names></name><name><surname>Cule</surname> <given-names>M</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Harding</surname> <given-names>RM</given-names></name><name><surname>Donnelly</surname> <given-names>P</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Evolutionary dynamics of <italic>Staphylococcus aureus</italic> during progression from carriage to disease</article-title><source>PNAS</source><volume>109</volume><fpage>4550</fpage><lpage>4555</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113219109</pub-id><pub-id pub-id-type="pmid">22393007</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Velvet: algorithms for de novo short read assembly using de Bruijn graphs</article-title><source>Genome Research</source><volume>18</volume><fpage>821</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1101/gr.074492.107</pub-id><pub-id pub-id-type="pmid">18349386</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.30637.065</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Holden</surname><given-names>Matthew TG</given-names></name><role>Reviewing Editor</role><aff><institution>University of St Andrews</institution><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Severe infections emerge from commensal bacteria by adaptive evolution&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The reviewers find that the paper describes an interesting study of a large data set of <italic>Staphylococcus aureus</italic> genomes representing isolates from carriage and disease in the same individuals. By analysing genetic changes distinguishing the carriage and disease isolates, the study sheds light on the within-host adaptive evolution in an important opportunistic pathogen.</p><p>1) Using genome-level resolution, and taking into account within-host diversity, the study demonstrates that the invasive disease is primarily caused by the carried strain.</p><p>2) There were repeatable patterns of evolution in the infection isolates indicative of within patient mutation and selection and these differed from prevailing signals of selection at the species level.</p><p>3) Adaptations during infection are not necessarily advantageous for transmission, and therefore may disrupt the reproductive life cycle of <italic>S. aureus</italic>.</p><p>4) Genetic diversity was much lower amongst infecting isolates compared to colonizing isolates, a pattern which suggests a bottleneck or small founding population for infection.</p><p>5) There is an excess of protein altering variation in the variants that differentiate carriage isolates from disease isolates, but not in those found between carriage isolates or between disease isolates.</p><p>6) These variants are shown to be concentrated in genes and pathways relevant to host-interaction and disease causation, are not subject to excess variation in the general population.</p><p>The analysis is both detailed and comprehensive and uses appropriate tools and techniques, backed up with rigorous statistical tests. The study is based on a large cohort of patients, and includes multiple isolates from each condition (carriage and disease) in each patient, and provides and unprecedented view of the population structures in disease vs. colonization.</p><p>Essential revisions:</p><p>1) In referring to the origin of the <italic>S. aureus</italic> within the host, the authors use a mixture of terms. For example, the title refers to 'commensal bacteria', in the abstract there is refer to infections emerging from the 'nose microbiota', and also 'nose-colonizing bacteria'. In the introduction there is mention of 'asymptomatic carriage' and 'commensal components of the body's microbiota' and in the Discussion section there is 'commensal bacteria colonizing the nose'. Given the journal's general audience, the manuscript would benefit from some more general information in the introduction about <italic>S. aureus</italic> relationship with the host and carriage, i.e. the observation about variable carriage in the human population (for example Kluytmans, et al., 1997), and that the nose is regarded as the primary colonization site, although there are other colonization sites in humans (see Yang et al., 2010; see following points).</p><p>2) The authors could also aid interpretation by being more consistent with the use of terms to describe origin of the <italic>S. aureus</italic> within the host, and also use them to accurately represent the sampling that has been conducted. For example, the authors have sequenced colonies that have been selectively grown from nose swabs, and therefore it is confusing to refer to nose microbiota. Experimentally, the microbiota of the patients has not been genomically characterized, therefore it is somewhat misleading to refer to the microbiota in this way. Additionally, it infers that <italic>S. aureus</italic> is a constituent part of the microbiota, which is not the case (see point above Kluytmans et al., 1997).</p><p>3) <italic>S. aureus</italic> can colonize multiple sites-the pharynx, groin, axilla, rectum, etc. (Yang et al., 2010). In the description of the results there appears to be an assumption that the nares population represents the entire colonizing <italic>S. aureus</italic> population. The experimental design means that additional colonizing <italic>S. aureus</italic> diversity elsewhere on these individuals will not be captured, therefore the interpretation of the patterns of diversity they observe needs to be considered and qualified more fully in the discussions.</p><p>4) The results suggest that it is not necessarily the case that the infecting population comes from the host, as not every <italic>S. aureus</italic> infected patient has nares <italic>S. aureus</italic> colonization, and also their data indicate that ~10% of their isolates are unrelated. Looking at <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, it also seems that at least a few of the infecting populations were clearly mixed with distinct STs or outliers (patients 23, 61, and 90), as were a few of the colonizing populations (patients 29, 33, 36, 45, 77, 94). This complicates interpretation further, as it suggests that the infecting populations did not necessarily evolve on or within the patient, but may have been at least in part acquired independently. Given both of these issues, interpreting the direction of infection and colonization (as in <xref ref-type="fig" rid="fig1">Figure 1D-F</xref>) seems problematic. This would then seem to call into question the classification of variants into the B, C, D classes. Can the authors address these concerns to strengthen their classification?</p><p>5) The authors refer to some of the changes that they see in disease isolates as &quot;adaptive&quot; changes, and define adaptive changes in the Introduction as &quot;evolution in response to disease-associated, within-host selection pressures.&quot; However, the definition they seem to use throughout the text is more operational: (Introduction) &quot;enrichments in protein altering variants&quot;. A clearer definition is warranted. Can the authors clarify if they mean enrichments above baseline or expected rates as might be seen in &quot;relaxed&quot; purifying selection or neutrality, or are they referring more strictly to situations in which <italic>d<sub>N</sub>/d<sub>S</sub></italic> values are significantly greater than 1?</p><p>6) An important distinction in the definition of adaptation might be between adaptation that happened at the colonizing site that was later co-opted in disease, and evolution that truly was &quot;disease-associated&quot;. It may be interesting to consider Gould and Vrba's idea of &quot;exaptation&quot; in this context, where changes that evolved in another selective context become beneficial, for another reason, in a new context. It seems possible that the variants that arise in invasive disease may have evolved much earlier under selection in the colonizing site. In this regard, it may be possible to estimate the timing of certain mutations using molecular clock approaches (especially given the multiple isolates collected from each individual). Even if the mutations in question did, in fact, arise very quickly during the process of invasion, it would be interesting to know how much these rates differ from expected rates of evolution. Adding an analysis of inferred rates of evolution would greatly enhance this manuscript.</p><p>7) Toxicity is used throughout the text and is a general term, which can encompass multiple proteins and potential effects. It does not specify the kind of toxicity (e.g. cell death, superantigen activity), target of the toxicity, the effector of the toxicity, or the way it is measured. The general concept of &quot;toxicity&quot; is qualitatively different from phenotypes like &quot;abscess formation&quot; or &quot;quorum sensing&quot; which are specific and measureable. The authors could add clarity using a term like &quot;toxin production&quot;, or specifying, &quot;in vitro cell death&quot;.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.30637.066</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) In referring to the origin of the S. aureus within the host, the authors use a mixture of terms. For example, the title refers to 'commensal bacteria', in the abstract there is refer to infections emerging from the 'nose microbiota', and also 'nose-colonizing bacteria'. In the introduction there is mention of 'asymptomatic carriage' and 'commensal components of the body's microbiota' and in the Discussion section there is 'commensal bacteria colonizing the nose'. Given the journal's general audience, the manuscript would benefit from some more general information in the introduction about S. aureus relationship with the host and carriage, i.e. the observation about variable carriage in the human population (for example Kluytmans, et al., 1997), and that the nose is regarded as the primary colonization site, although there are other colonization sites in humans (see Yang et al., 2010; see following points).</p></disp-quote><p>Thank you for highlighting this important issue. From the outset, we have tried to assist comprehension for a general audience by avoiding field-specific terms such as ‘isolates’ and we subsequently identified mixed terminology as a difficulty in our drafting process, so I am grateful to the reviewers for flagging that our efforts to clarify the usage have not gone far enough. The paper now clarifies throughout that colonizing bacteria refers to the nose. I have adopted rigid use of infection in preference to disease and expurgated invasion as an unnecessary qualifier. I have cited the suggested papers and expanded on the points immediately relevant to this study in the Introduction.</p><disp-quote content-type="editor-comment"><p>2) The authors could also aid interpretation by being more consistent with the use of terms to describe origin of the S. aureus within the host, and also use them to accurately represent the sampling that has been conducted. For example, the authors have sequenced colonies that have been selectively grown from nose swabs, and therefore it is confusing to refer to nose microbiota. Experimentally, the microbiota of the patients has not been genomically characterized, therefore it is somewhat misleading to refer to the microbiota in this way.</p></disp-quote><p>I have removed mention of the microbiota extensively, in particular wherever it could mislead readers into thinking we have performed metagenomic sequencing, rather than selectively growing <italic>S. aureus</italic>.</p><disp-quote content-type="editor-comment"><p>Additionally, it infers that S. aureus is a constituent part of the microbiota, which is not the case (see point above Kluytmans et al., 1997)</p></disp-quote><p>I regret that I do not follow this point. From the bacterium’s perspective, the human nose (and other body sites) is its natural niche, so surely it is accurate to define <italic>S. aureus</italic> as a constituent part of the nose microbiota, present in around 30% of healthy adults at any one time.</p><disp-quote content-type="editor-comment"><p>3) S. aureus can colonize multiple sites-the pharynx, groin, axilla, rectum, etc. (Yang et al., 2010). In the description of the results there appears to be an assumption that the nares population represents the entire colonizing S. aureus population. The experimental design means that additional colonizing S. aureus diversity elsewhere on these individuals will not be captured, therefore the interpretation of the patterns of diversity they observe needs to be considered and qualified more fully in the discussions.</p></disp-quote><p>It is true that <italic>S. aureus</italic> colonize body sites other than the nose less frequently and, as requested, in the Introduction we now make this plain, citing the additional reference.</p><p>I certainly wouldn’t want our claims to rest on a false assumption that the nose represented the entire colonizing population. I don’t believe there are any points in the paper where this occurs, I believe that our interpretations have always carefully considered this caveat, and I do not believe there are any conclusions in the Discussion section or elsewhere that rest on such an assumption. The improvements in terminology, where reference to colonization is now always qualified as nose-colonization, should make this clear when perhaps previously it wasn’t.</p><disp-quote content-type="editor-comment"><p>4) The results suggest that it is not necessarily the case that the infecting population comes from the host, as not every S. aureus infected patient has nares S. aureus colonization, and also their data indicate that ~10% of their isolates are unrelated. Looking at <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, it also seems that at least a few of the infecting populations were clearly mixed with distinct STs or outliers (patients 23, 61, and 90), as were a few of the colonizing populations (patients 29, 33, 36, 45, 77, 94). This complicates interpretation further, as it suggests that the infecting populations did not necessarily evolve on or within the patient, but may have been at least in part acquired independently. Given both of these issues, interpreting the direction of infection and colonization (as in <xref ref-type="fig" rid="fig1">Figure 1D-F</xref>) seems problematic. This would then seem to call into question the classification of variants into the B, C, D classes. Can the authors address these concerns to strengthen their classification?</p></disp-quote><p>The reviewers are absolutely right that the valid interpretation of the results of any within-host study relies on the identification of variants that truly arose within-host. This is a point on which we have taken great care:</p><p>As the reviewers note, we began the Results section by stating clearly that in 10 patients, the invasive <italic>S. aureus</italic> were unrelated to the nose-colonizing <italic>S. aureus</italic>. At the end of this paragraph, we stated that we excluded variants differentiating unrelated STs from further analysis. I have now clarified that in one of these 10 patients, nose-colonizing and infecting bacteria possessed the same ST but differed by 1104 variants, far outside the within-ST variation evident in any individual nose or infection site (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), and corresponding to around 70 years of divergence based on our previous estimates of within-host evolution (Young et al., 2012), which are consistent with others’ estimates from between-host evolution (e.g. Harris et al., 2010). The other nine with unrelated STs differed by 9398-50573 variants.</p><p>The key consideration is what threshold to apply to distinguish related from unrelated nose and infecting bacteria. <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> is designed to make transparent our reasoning: as the legend states, “When the number of B-class variants was 66 or less, nose-colonizing and infecting bacteria were considered related, since a similar range of (C-class) diversity was observed within the nose-colonizing populations of bacteria with the same multilocus sequence type. When the number of B-class variants was 1104 or more, nose-colonizing and infecting bacteria were considered unrelated.”</p><p>The choice of threshold was clear-cut in these patients, as can be seen from comparing the empirical distributions of B, C and D-class variants in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. This is one of the benefits of having sequenced multiple colonies per body site. However, as noted above we were also guided by past studies that we (and others) conducted, which show the <italic>S. aureus</italic> substitution rate is around 8 variants per genome per year. So the 66-variant threshold represents 4.1 years since the nose and infection populations diverged, within the range of diversity we saw among C-class variants.</p><p>The reviewers are right to note that there were interesting signals in our data that we did not dwell on because the focus of the study was the role of de novo mutation and selection within patients. For example, we did indeed show in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> that in nine of the 95 patients with extremely closely related nose-colonizing and infecting bacteria, there were also present <italic>S. aureus</italic> of another, unrelated ST. We now specifically alert readers at the beginning of the Results, making clear that these unrelated populations were excluded from further analysis. It would be tempting to devote more space to the multiply infected patients but the paper is already complex and a sample size of three is too small to draw meaningful conclusions without the ethical approval to explore their case histories.</p><p>I must push back on the suggestion that these real-world complexities pose problems for inferring, in cases where there are closely related nose-colonizing and infecting bacteria, whether the nose-colonizing bacteria are ancestral to the infecting bacteria (e.g. <xref ref-type="fig" rid="fig1">Figure 1D</xref>), vice versa (e.g. <xref ref-type="fig" rid="fig1">Figure 1F</xref>), or indeed making no conclusion (e.g. <xref ref-type="fig" rid="fig1">Figure 1E</xref>). We are able to make these inferences because we leveraged multiple colony sequencing to identify novel mutations that had recently arisen in one population, the hallmark of which being the observation of both ancestral and mutant alleles, and then we observed the new mutant allele fixed in the other population. This same sequencing strategy enabled us to classify mutations that differentiated the nose-colonizing from infecting bacteria (B-class) from those that varied within the nose only (C-class) or infection site only (D-class) with 91% power, as explained in the Materials and methods section Power calculation for within-patient sample sizes.</p><disp-quote content-type="editor-comment"><p>5) The authors refer to some of the changes that they see in disease isolates as &quot;adaptive&quot; changes, and define adaptive changes in the Introduction as &quot;evolution in response to disease-associated, within-host selection pressures.&quot; However, the definition they seem to use throughout the text is more operational: (Introduction) &quot;enrichments in protein altering variants&quot;. A clearer definition is warranted. Can the authors clarify if they mean enrichments above baseline or expected rates as might be seen in &quot;relaxed&quot; purifying selection or neutrality, or are they referring more strictly to situations in which d<sub>N</sub>/d<sub>S</sub> values are significantly greater than 1?</p></disp-quote><p>The reviewers are right to insist on a crystal-clear definition of what evidence warrants the use of the term ‘adaptive’ when applied to genetic differences, a term that is the subject of very wide misuse, and frequently applied with little or no more than an assertion.</p><p>As the reviewers rightly highlight, we defined this in the Introduction and I have now clarified it to say, “We discovered several groups of genes showing significant enrichments of protein altering variants compared to other genes, indicating adaptive evolution”. This is our principal use of the term, and we describe the precise technical criteria to meet statistical significance in the subsections “Gene enrichment analysis” and “Gene set enrichment analysis”. Occasionally, and where clearly stated, we inferred evidence of adaptation based on the <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio, e.g. from a Reference Panel using omegaMap (Wilson and McVean, 2006).</p><p>As requested, I have further clarified at the beginning of the Results section “Quorum sensing and cell adhesion proteins exhibit adaptive evolution between nose-colonizing and infecting bacteria” that the gene enrichment analyses detect evidence for adaptation when there is a significant enrichment of protein-altering variants in a particular gene compared to other genes.</p><p>The question of whether an enrichment of protein-altering variants compared to other genes is truly indicative of adaptive evolution is an important one. Strong gene-specific and gene-set-specific enrichments of B-class variants are unlikely to reflect relaxed constraint, which should manifest as a fairly homogeneous pattern across genes. Nevertheless, I have introduced a new table (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) that explicitly presents, for all the significant enrichments shown in <xref ref-type="table" rid="table3">Table 3</xref>, Neutrality Indices that support the interpretation of these enrichments as evidence for adaptive evolution.</p><p>The Neutrality Index (Rand and Kann, 1996, McDonald and Kreitman, 1991) is able to infer adaptive evolution even when a test based solely on <italic>d<sub>N</sub>/d<sub>S</sub></italic> would not because it does not make the same, overly stringent, null hypothesis of strict neutrality in which equal rates of protein-altering and non-protein altering variation are assumed. Instead, the Neutrality Index effectively compares the <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio between populations (i.e. the B-class variants) to the <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio within populations (i.e. the C/D-class variants). Selection is expected to have left a stronger imprint on inter-population (B-class) variation because it has had longer to act on older variants. For that reason, a Neutrality Index above one (a greater <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratio in B- versus C/D-class variants) would be interpreted as adaptive evolution even in cases if the absolute <italic>d<sub>N</sub>/d<sub>S</sub></italic> ratios were both below one. Note that this test is helpful for interpretation but we did not use it as the main test because it is less powerful than the test for gene or gene set specific enrichments of protein-altering B-class variants.</p><disp-quote content-type="editor-comment"><p>6) An important distinction in the definition of adaptation might be between adaptation that happened at the colonizing site that was later co-opted in disease, and evolution that truly was &quot;disease-associated&quot;. It may be interesting to consider Gould and Vrba's idea of &quot;exaptation&quot; in this context, where changes that evolved in another selective context become beneficial, for another reason, in a new context. It seems possible that the variants that arise in invasive disease may have evolved much earlier under selection in the colonizing site. In this regard, it may be possible to estimate the timing of certain mutations using molecular clock approaches (especially given the multiple isolates collected from each individual). Even if the mutations in question did, in fact, arise very quickly during the process of invasion, it would be interesting to know how much these rates differ from expected rates of evolution. Adding an analysis of inferred rates of evolution would greatly enhance this manuscript.</p></disp-quote><p>This is a really interesting point and one that we would have loved to investigate in more detail. I agree that the reviewer’s theory of exaptation is very plausible. For a well-powered statistical analysis, a sampling frame that was equally large but with longitudinal sampling to capture the nose population prior to invasion would be ideal. We have achieved this with one patient (Young et al., 2012), but obtaining large patient numbers currently seems remote.</p><p>The BEAST analysis is also a great suggestion, one that we contemplated during the study, and one of several interesting potential follow-up analyses. However, given the current complexity of the paper and the methods used in it, together with reservations over statistical power, we decided against including such an analysis. Nevertheless, the data will be released into the public domain so colleagues interested in pursuing this will be able to as soon as the paper is published.</p><p> <italic>7) Toxicity is used throughout the text and is a general term, which can encompass multiple proteins and potential effects. It does not specify the kind of toxicity (e.g. cell death, superantigen activity), target of the toxicity, the effector of the toxicity, or the way it is measured. The general concept of &quot;toxicity&quot; is qualitatively different from phenotypes like &quot;abscess formation&quot; or &quot;quorum sensing&quot; which are specific and measureable. The authors could add clarity using a term like &quot;toxin production&quot;, or specifying, &quot;</italic>in vitro <italic>cell death&quot;.</italic></p><p>We have clarified by using “toxin production” or “cytotoxicity” where unclear.</p></body></sub-article></article>